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ABSTRACT OF DISSERTATION

REGULATION OF SKELETAL MUSCLE PLASTICITY BY THE GUT
MICROBIOME

Recent evidence suggests that the gut microbiome could play a role in skeletal
muscle plasticity, providing novel treatments for muscle wasting diseases and/or
performance enhancements. I first sought to determine if the gut microbiome is
necessary for skeletal muscle adaptation to exercise. Forty-two, four-month old,
female C57Bl/6J underwent nine weeks of weighted wheel running or remained
in cage with a locked wheel, without or without the administration of antibiotics
(treated). In response to wheel running, I found that antibiotic depletion of the
microbiome led to a blunted hypertrophic response in the soleus muscle as
measured by normalized muscle wet weight and mean and fiber-type specific
cross-sectional area (CSA). The plantaris muscle of mice who ran with antibioticinduced dysbiosis showed a blunted glycolytic to oxidative fiber-type shift,
decreased myonuclear accretion and satellite cell abundance compared to nontreated runners. These results are the first to demonstrate that an intact
microbiome is necessary for skeletal muscle adaption to exercise.
I next tested if the gut microbiome mitigates skeletal muscle atrophy
induced by hind limb immobilization. Eighteen, four-month old, female C57Bl/6J
mice were divided into two groups (n=9/group), that received cecal microbial
transfers from either exercise-trained or sedentary donors. After four weeks of
cecal transplants, the recipient mice underwent 10-days of single leg hind-limb
immobilization. Immunohistochemistry analysis revealed that the recipients of the
exercise-trained donors experienced significantly less skeletal muscle atrophy of
the soleus muscle, as measures by mean fiber and fiber-type specific CSA. The
transfer of microbiome from exercise-trained donors also led to a preservation of
Type-2A fibers in the immobilized soleus muscle. These results demonstrated that
the transfer of a microbiome from an exercise-trained host into recipients
mitigated skeletal muscle atrophy, in addition to the persevering Type-2A fibers
abundance during atrophy
To better understand how the gut microbiome acts to modulate skeletal
muscle mass and fiber-type composition, metagenomic sequencing was
performed on donor and recipient of exercise-trained and sedentary cecal content.
Sequencing data revealed significant differences in the microbiome between the
two recipient groups. Further microbial functional comparisons were made and
distinguished significant associations in fucose degradation and histidine
metabolism in the recipients who received microbiome from exercised-trained

donors. To further interrogate the metagenomic sequencing, microbial sequence
features were analyzed with MelonnPan to determine predictive metabolites
associated with each recipient group. Lipids and bile acids metabolites were
significantly associated with the recipients of the exercise-trained donors. There
was a trend for imidazole propionate to be associated with the recipients of the
exercise-trained donors. The metagenomic analysis indicated the microbiome
from an exercise-trained host was associated with metabolic pathways that
generate short chain fatty acids (fucose degradation) and the histidine-derived
metabolite imidazole propionate.
The results from this dissertation provide evidence of crosstalk between
skeletal muscle and the gut microbiome, providing for the first-time data that
demonstrates the gut microbiome influences both anabolic and catabolic signaling
in skeletal muscle. Although a direct mechanism for the skeletal muscle-gut
microbiome interaction was not found, the metabolites propionate and imidazole
propionate were identified as possible candidate for future studies. A general
conclusion from the two studies described in this dissertation provides new
evidence for the regulation of skeletal muscle mass and fiber-type composition.
Future work will need to focus on the identification of the gut microbialderived metabolites promote anabolic pathways in skeletal muscle. Additional
studies should also determine if the attenuation in atrophy induced by hind limb
immobilization is conserved in other models of atrophy as observed with skeletal
muscle wasting diseases and space exploration.
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INTRODUCTION: SKELETAL MUSCLE AND THE GUT MICROBIOME
CHAPTER 1. SKELETAL MUSCLE AND THE GUT MICROBIOME
Skeletal Muscle
Skeletal muscle is one of the largest organs of the body, accounting for roughly 3540% of body weight [1]. It is comprised of long, multinucleated cylindrical fibers, which
are stable in G0 and considered to be post-mitotic [2]. Skeletal muscle is extremely plastic,
that is skeletal muscle specifically adapts to changes in the type and level of contractile
activity it experiences [3]. Perturbations in muscle can be both beneficial (exercise) and
deleterious (disuse/disease). At the onset of injury, skeletal muscle possesses the ability to
regenerate due to the presence of a stem cell population, known as satellite cells, and other
supporting cells [4]. Skeletal muscle is also considered to be a secretory organ, whereby it
secretes factors, termed myokines and extracellular vesicles which can be taken up by
various tissues [5-8], providing a mechanism for how skeletal muscle may contribute to
systemic health.
Skeletal muscle loss occurs during physical inactivity, systemic disease,
immobilization, and aging, thereby contributing to an increased risk for morbidity,
disability, poor prognosis/recovery and dramatically decreasing quality of life [9-11]. Loss
of muscle can occur within a few days as shown by Kouw and colleagues who found that
quadriceps and thigh muscle cross sectional area (CSA) decreased 3.4% and 4.2%,
respectively, in just 5.6 days after hip surgery [12]. Individuals with the lowest skeletal
muscle mass index were reported to have significantly more hospitalizations, which
amount to roughly $1,200 in extra medical cost per person [13]. Financial reports have
estimated a total of $18.5 billion in healthcare costs due to the loss of skeletal muscle [14].
The prevalence of skeletal muscle loss ranges in at-risk patients ranges from 10% in
chronic heart failure, 30% in cancer, 35% in chronic obstructive pulmonary disease and
50% in end-stage renal disease [15].
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Treatments aimed at preventing the loss of skeletal muscle include exercise, nutrition
and pharmacological interventions; however, these treatments may not always be the most
appropriate or impactful. Nutritional interventions may only provide modest benefits in
combating atrophy [16] and could become problematic due to cost, satiety and poor taste
[17]. Furthermore, these interventions may not be the most appropriate and applicable. For
example, in extreme cases of cachexia, the patient may be unable to exercise. Side effects
of pharmacologic interventions such as testosterone, have also been reported which include
liver damage[18] and cardio-vascular related events [19]. Identifying alternative treatment
strategies is paramount to combat conditions in which muscle loss is a major outcome as
the onset of muscle loss can be rapid [10].
The cellular and molecular mechanisms that govern skeletal muscle plasticity
continue to be a progressive field of study [20-22]. Currently the area of small metabolite
regulation is receiving great interest within skeletal muscle biology field [23] due to the
highly complex, and unknown nature of how metabolites modify regulatory pathways in
skeletal muscle, alter the metabolic program and modify histones. These non-canonical
signaling pathways represent potentially new strategies to therapeutically intervene to
combat conditions where there is a loss of skeletal muscle mass and function. Skeletal
muscle is unique in its ability to rapidly alter its metabolism when transitioning from a
period of rest to exercise [24, 25]. Metabolic intermediates such as succinate, isoleucine,
acetyl-CoA, lactate, methyl group, glutamate, crontyl-CoA, malonyl-CoA and ketone
bodies generated from pathways are involved in post-translation modifications of histones
and non-histone proteins [26-29]. This presents new insights of how metabolic factors
contribute to skeletal muscle biology. The next sections will outlie the development of
skeletal muscle, structural anatomy and provide mechanisms that mediate skeletal muscle
hypertrophy and atrophy.
Myogenesis: The Development of Skeletal Muscle
During gastrulation, the primitive streak forms giving rise to three primary germ
layers; the endoderm, the mesoderm and the ectoderm. Gastrulation also marks the time
when cells will become committed to a specific fate, following a series of molecular and
cellular events that control the progression of development [30]. Skeletal muscle arises
2

from the mesoderm, specifically the paraxial mesoderm (PM) which forms directly lateral
to the neural tube [31]. Segmented portions of the PM interact with the presomatic
mesoderm (PSM), developing into somites which progress in a rostral to caudal orientation.
The somites eventually differentiate into the dermomyotome and then give rise to the
vertebral and limb muscles [32-34]. The dermomyotome contains muscle stem cells and
can be further segmented into the hypaxial and epaxial domains in which distinct
innervation patters control specific muscle populations. For example, expaxial muscles
(muscles of the back) are innervated by the dorsal branch of the spinal nerve, while
hypaxial muscles (body wall muscles, appendicular muscles, diaphragm and tongue
muscles) are innervated by the ventral spinal nerves [35]. In these specific sites of skeletal
muscle formation, terminal differentiation is governed by a group of four basic helix-loophelix domain myogenic regulatory factors (MRF); Myogenic factor 5 (Myf5), myogenic
factor 6 (Myf6, sometimes referred to Myf4), myogenic differentiation 1 (MyoD) and
myogenin (MyoG) [32, 35, 36]. These transcription factors initiate the cascade of events
resulting in the formation of post-mitotic, multinucleated mature muscle fibers. Myf5
appears to be the first expressed MRFs during embryogenesis at embryonic day 8 [37]. In
addition, important signaling cues from upstream transcription factors helps to regulate the
MRFs during myogenesis allowing for muscle progenitor cells to proliferate and
differentiate into mature myotubes [35].
Cells that comprise the newly formed somites have not yet differentiated into a
specific tissue lineage. As reviewed by Maracelle and co-workers, wingless integrated
(Wnt), bone morphogenic protein (BMP) and sonic hedgehog (Shh) are major signaling
factors that initiate fate determination in somites [38]. Somites will begin to differentiate
into various tissues with the medial, lateral and central epithelial somites giving rise to
Pax3/Pax7 positive progenitors [39, 40]. The paired box gene 3 (Pax3) was shown to be
highly expressed during the developing dermomyotome [41, 42]. Once the dermomyotome
is formed, cells will down-regulate Pax3 expression and begin to express Myf5 and Myf4
prior to myotome formation [43]. Pax3 has been shown to activate Myf5 expression by
binding to a regulatory element located upstream of the Myf5 transcription start site [44].
Additionally, it was shown that the sine occulis homeobox homologue 1 and 4 (Six 1 and
Six 4) regulate Myf5 expression in conjunction with Pax3 at the same upstream cis-element
3

[45]. Other factors such as Shh, Gli transcription factors and doublesex and mab-3 related
transcription factors have been shown to activate Myf5 [46, 47]. The elevated levels of
Myf5 leads to the expression of MyoD which is also thought to be under the regulation of
Pax3 in the epaxial muscles, whereas Six 1 and Six 4 regulate MyoD in the hypaxial
muscles. The increase in MyoD expression promotes myoblast proliferation and
subsequent differentiation. This event marks the irreversible exit from the cell cycle and
terminal differentiation. At this stage of myogenesis, myotubes will fuse into mature
myofibers which will express specific myosin heavy chain isoforms (MyHC) (discussed in
section 1.1.2)
Satellite Cells: Skeletal Muscle Resident Stem Cells

Skeletal muscle fibers contain multipotent resident stem cells that reside underneath the
basal lamina, which also develop from the dermomyotome [48, 49]. At the time of postnatal development in the mouse, muscle stem cells (MuSC also termed satellite cells), will
account for roughly 30% of the nuclei within muscle whereas by adulthood, satellite cells
will account for <5% of myonuclei [50, 51]. During cell division, satellite cells will
replicate in a symmetric or asymmetric fashion where they give rise to two daughter cells
with distinct fates; differentiation into mature myoblast or replenish the existing stem cell
population [52]. Satellite cells, express Pax7, a paralog of Pax 3, which forms the pool of
adult muscle stem cells residing between the basal lamina and sarcolemma [53]. Pax7 was
shown to be necessary to direct the specification of satellite cells [54]. Satellite cells reside
in a quiescent state, and upon activation, proliferate, differentiate, then fuse into the mature
muscle fibers and/or communicate with other cell populations that exist within skeletal
muscle environment [55-57]. Satellite cells will begin to express Pax7 and commit to the
satellite cell lineage inducing myogenic differentiation. In terms of self-renewal, dividing
satellite cells depends on NOTCH2 and DELTA1 signaling to maintain the satellite cell
population [58]. The transition of a satellite cells from a quiescent state to a proliferation
state, is also accompanied by a shift in their metabolism, primarily from fatty acid oxidation
to glycolysis [59]. Thus, different genetic networks and metabolic programs initiate and
control fate determination of satellite cells which allows for precise governing of these
stem cells during muscle plasticity in post-miotic mature muscle fibers. Elucidating how
4

different stimuli such as injury, exercise and various pathologies affect the behavior of
satellite cells is of great interest and could help to identify other potential factors that
contribute to the development and maintenance of skeletal muscle.
One final contributing factor to myogenesis is through epigenetic control of MRFs
and other important genes that control muscle development. One form of epigenetic
regulation involves specific enzymes that modify particular amino acid residues on
histones [60]. During skeletal muscle development, gene expression has been shown to be
regulated by certain epigenetic events [61, 62]. Recently Zhu and co-workers found that
the histone lysine demethylase (KDM4A), drove the expression of MyoD and MyoG. New
insights into epigenetic regulation have shown that a multitude of different enzymes and
substrates participate in the modification of histones and non-histone proteins [29, 63].
Yucel and co-workers demonstrated that satellite cells redirect their metabolism in order
to modulate histone acetylation as a driving factor in myogenic fate determination [64].
These results suggest that epigenetic regulation of satellite cells appears to be critical to
myogenic function and behavior.
The Structural Basis of Skeletal Muscle
The hierarchy of skeletal muscle anatomy provides one of the best examples of
structure-function relationships that exist in biology [65]. Visibly, one can discern gross
anatomical differences between various muscles based upon the varying architectural
properties. Skeletal muscle architecture, or the arrangement of muscle fibers (myofibers)
relative to the axis of force generation [66, 67], contributes to overall muscle function,
allowing for a diverse range of characteristics when considering the roughly 650 different
muscles within the human body. A muscle is composed of bundles of fascicles which
themselves are composed of thousands of muscle cells known as myofibers. In horses,
Grotmol and co-workers found the average number of fascicles per muscle was roughly
20. These authors also determined the average muscle fiber per fascicle ranged between
140-200 fibers depending if the fascicle was superficial or deep [68]. The myofiber itself
is packed with myofibrils which are primarily composed of the thin actin myofilament and
the thick, myosin, myofilament. The myofilaments are arranged into the sarcomere which
is the smallest functional unit of muscle contraction [69]. In addition to actin and myosin,
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the sarcomere is comprised of many other proteins that enable the contraction of muscle
(described below). While viewing whole muscle, it can be seen that myofibers are arranged
such that they may run parallel to the axis of force generation (longitudinal) or they can
run at one fixed (unipennate) or several (multipennate) angles relative to the axis of force
generation [67]. These inherent anatomical differences allow for myofibers of roughly the
same diameter and composed of the same proteins to perform different functions such as
force production or excursion [67].
Skeletal muscle is surrounded by different layers of connective tissue that
compartmentalize muscle fibers. These layers are the epimysium which ensheathes the
entire muscle, giving rise to the tendons; the perimysium surrounds each fascicle within
the muscle, and the endomysium surrounds each individual myofiber [70]. Beneath the
endomysium, the muscle cell is surrounded by a basement membrane, known as the basal
lamina which constitutes the extracellular matrix (ECM). These layers of connective tissue
function to connect muscle to bone, faithfully transmit force and participates in muscle
repair after injury [71-73]. This surrounding connective tissue meshwork also consists of
various collagens, glycoproteins, proteoglycans and elastins which contributes to the
overall structure and signaling cascades within a muscle [70, 74].
Within each myofiber, there are approximately 500-10,000 myofirbils which are
composed of millions of functional units called sarcomeres [65]. Sarcomeres are 2-3µm in
length and 1µm in diameter [65]. Sarcomeres are defined laterally by Z-discs that anchor
the actin containing thin filaments in an anti-parallel fashion, with additional proteins,
nebulin, α-actinin, myozenin, myotilin, myopalladin and titin providing structural and
mechanical support [75]. Adjacent to each Z-discs are regions of the sarcomere known as
the I-band which contain only actin thin filaments [76]. In the center of each sarcomere is
the M-band which anchors the myosin containing thick filaments. The H-zone, located in
the center of the M-band, contains only thick filaments and are flanked by regions known
as the A-bands, which contain both myosin and actin filaments. The force of muscle
contraction is generated by a shortening of the sarcomere when the thin myofilament is
pulled through the action of the thick myofilament to the center of the sarcomere.
According to the sliding filament mechanism, the globular heads of myosin heavy chain
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become activated and bind to exposed myosin binding sites on the actin filaments forming
a cross-bridge. Through the hydrolysis of ATP and the subsequent dissociation of the
inorganic phosphate, the myosin heads under a conformation change which effectively pull
the actin myofilaments towards the M-band in what is known as the power stroke [75, 77,
78]. New findings on the molecular basis for skeletal muscle contraction and sarcomere
organization are still being discovered, highlighting the complexity of myofilament
interactions during muscle contraction [79].
Myofibrillar organization does not only include the contractile machinery
mentioned above, but also consists of the cytoskeletal and other membrane-bound
organelles typical of all cells [80]. Proteins associated with these structures provide
connection points between the sarcomeres and organelles, supports the contractile
apparatus, participates in mechanotransduction and signaling cascades which regulate
skeletal muscle plasticity [69]. The presence of proteins such as integrins, which span from
the sarcolemma to the ECM, allows for bidirectional signaling to take place between the
internal and external environments of the muscle fiber [81]. First described in 1983 by
Criag and Pardo, costameres localized over the Z-discs, link the sarcolemma to the
cytoskeleton [80, 82, 83]. Costameres are protein assemblies, mainly consisting of two
major complexes, 1) the dystrophin-glycoprotein complex (DGC) and 2) the integrinvinculin-talin complex [84]. These protein assemblies help to transmit force from the
sarcolemma to the surrounding extracellular matrix and may contribute to the organization
of thin and thick filaments [85]. The critical role of these other myofibrillar proteins in
muscle function is easily seen when considering pathologies such as muscular dystrophy.
For example, a mutation in dystrophin gene can lead to either reductions in the amount of
dystrophin protein or in more severe cases, the complete loss of the dystrophin protein [86,
87]. Finally, components of the ECM and the protein titin contribute to the force of passive
stiffness observed when a muscle is stretched in the absence of cross-bridge activation
[88].
Architectural differences result in whole muscle variations allowing for specific
roles for each muscle found within the body. Each muscle is composed of different type
of myofibers that contribute to functional characteristics of a muscle. There are three major
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types of myofibers, slow-twitch, fast-oxidative and fast-glycolytic, that exhibit distinct
phenotypic properties. One of the major differences in fiber-type is due to the expression
of specific adult myosin heavy chain proteins. There are three primary myosins in human
and four in rodents expressed throughout the muscles of the body with other myosins
restricted to development or specialized muscles [89]. The functional characteristics of
each fiber-type can also be attributed to differences in fiber size, pattern of neural
innervation, metabolism and force production [90]. Slow-twitch muscle fibers (MYH7,
Type 1) are characterized by having a slow time to peak tension, high capacity for lipid
oxidation, enriched with mitochondria, highly vascularized and are fatigue resistant [75,
91]. Fast oxidative (MYH2, Type 2A) fibers exhibit faster time to peak tension, highly
oxidative with a greater propensity for glycolysis compared to slow-twitch fibers and are
also fatigue resistant [92]. The fast-glycolytic fibers (MYH1,Ttype 2X, in humans, MYH
1 and MYH 4, Type 2B in rodents) generate peak tension the fastest of myofibers, exhibit
a high reliance on glycolytic metabolism, relatively low mitochondrial content and are
highly fatigable [93]. With the advantage of cutting-edge techniques, such as single-cell
RNA--sequencing, Rubenstein and co-workers determined specific gene signatures for
Type 1 and Type 2A muscle fibers which showed differential expression of sarcomeric,
calcium transport and metabolic genes between the two fiber types [94].
Mechanisms of Skeletal Muscle Hypertrophy
Skeletal muscle has the extraordinary ability to remodel the size and physiological
characteristics in response to mechanical loading, contractile activity, anabolic signaling,
nutrient availability and/or metabolic changes [95-98]. Skeletal muscle responds to these
stimuli by increasing the size of each muscle fiber (hypertrophy), while the addition of new
muscle fibers (hyperplasia) is minimal if at all under normal situations. The cellular and
molecular pathways that govern skeletal muscle hypertrophy act to modulate the balance
of protein synthesis and breakdown. Increasing the rates of protein synthesis while
mitigating protein degradation will lead to skeletal muscle growth [99]. The cell’s master
regulator of protein synthesis is known as mechanistic target of rapamycin (TORC-1 or
TORC-2, described below), a serine/threonine protein kinase [100]. Additional pathways
that are thought to TORC-1 be independent also contribute to skeletal muscle hypertrophy
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but will not be the focus of this section [101]. In order to increase protein synthesis, the
myofiber needs to modulate two primary factors- 1) translational efficiency; the amount of
mRNA that is successfully translated into protein and 2) translational capacity; how much
translational machinery (ribosomes) are available [97]. These factors are controlled by the
cells ability to increase ribosome biogenesis which facilitates an increase in mRNA
translation.
TORC-1 has been shown to regulate both transcriptional efficiency and capacity,
leading to enhanced protein synthesis and subsequent hypertrophy [20]. TORC-1 promotes
to the synthesis of ribosomal RNA (rRNA) by activating the transcription factors
Transcription Initiation Factor 1a (TIF1a) and Upstream Binding Factor (UBF) which
upregulate the activity of RNA polymerase 1 (Pol I) [102, 103]. The regulation of the 79
ribosomal proteins (RP) is also thought to be under the control of TORC-1 activation of
RNA Pol II [104]. All the mammalian mRNAs for RPs contain a 5’-terminal
oligopyrimidine tract (5’-TOP), in addition to other non-RP mRNAs[105]. Using an
TORC-1 ATP site inhibitor, Hsieh and co-workers determined that 68% of the 144 TORC1 sensitive genes were 5’-TOP mRNAs [106]. This implies that TORC-1 regulates
ribosome biogenies through interacting with some RPs. Another substrate for TORC-1 is
p70S6 kinase (p70S6K) which, when activated by TORC-1, phosphorylates ribosomal
protein S6 (rpS6) [107]. Activation of rpS6 facilitates the translation of 5’-TOP mRNAs,
leading to enhanced synthesis of proteins required for translation [108] The activation of
TORC-1 can also phosphorylate and inhibit Maf1, a repressor of rRNA Pol III[109].
Additionally, TORC1 also associates with RNA Pol III through the interaction with
Transcription Factor IIIC which was shown to be crosslinked with tRNA and 5S rRNA
genes, both of which are transcribed by RNA Pol III [109]. These studies demonstrate that
TORC-1 acts to increase ribosome biogenesis by increasing the translational machinery
required to enhance protein synthesis. Another downstream target of TORC-1 is eukaryotic
translation initiation factor 4E binding protein (4E-BP1) [110]. By phosphorylating and
inactivating 4E-BP1, mRNA translation initiation and elongation is enhanced [111]. The
phosphorylation of 4E-BP1inhibits its repression of Eukaroytic Initiation Factor 4E (eIF4e)
which recruits the translational initiation machinery (eIF3, eIF4A, eIF4B and eIF4G) to the
5’ cap of mRNA facilitating the binding of ribosomes [112]. These studies highlight the
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central role of mTOR in the regulation of cellular growth and its significant role in skeletal
muscle hypertrophy.
In 1999 Baar and Esser demonstrated that prolonged muscle contraction, induced
by electrical stimulation of the sciatic nerve, resulted in a significant increase in skeletal
muscle hypertrophy in rats [113]. These authors found the high force contractions lead to
the phosphorylation of the TORC-1 substrate p70S6K , with a concomitant increase in
polysome profiles during the first six hours after stimulation, suggesting increases in
protein synthesis as a result of force production [113]. The importance of TORC-1
signaling during hypertrophy was further highlighted by Bodine and co-workers. They
demonstrated that blocking TORC-1 by the administration of rapamycin rendered the
plantaris muscle unable to grow in response to synergist ablation [114]. In addition, these
authors showed that the upstream kinase (protein kinase B/Akt), was necessary for TORC1 activation and subsequent skeletal muscle hypertrophy [114].
mTOR exists in two different protein complexes, TORC-1 and TORC-2, distinct
from one another in binding partners and substrates. TORC-1 associates with the
rapamycin-sensitive protein RAPTOR, while TORC-2 contains RICTOR, which is
rapamycin-insensitive. These proteins provide a scaffold by which TOR substrates can
assemble and bind to the kinase domain located at the C-terminal of TORC-1/2 [115, 116].
Additional components of the TORC-1 complex include the mammalian lethal with sec13 protein 8, mLST8/GβL (TORC-1) and mLST8/Gbl (TORC-2), DEP domain containing
TOR-interacting protein (DEPTOR) and Ttil1 and telomer maintenance 2 (Tel2) [115, 117]
Less is known about the TORC-2 complex and its function in skeletal muscle with one
study showing that TORC-2 is important for glucose uptake during exercise [118]. TORC1 on the other hand is the master regulator of protein synthesis [96]. Growth factors binding
to their receptors on the sarcolemma (insulin like growth factor, frizzled homolog 7 and βAdrenergic receptors) initiates the autophosphorylation on tyrosine residues on these
receptors. This phosphorylation recruits phosphatidyl-inositol-3-kinase (PI3K) to the
membrane, which binds to the phosphotyrosine residues of the growth factor receptors.
The activation of PI3K results in the phosphorylation of the inositol ring of the membrane
phospholipid phosphatidylinositol-3,4,5-triphosphate (PI3,4,5-P3/PIP3) by the catalytic
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subunit (p110) of PI3K [119]. PIP3 recruits signaling proteins containing a pleckstrin
homology (PH) domain such as Akt.
Akt phosphorylates and inhibits the GTPase activating protein (GAP)- tuberous
sclerosis complex 2 (TSC2) [120]. The inactivation of TSC2 leads to the accumulation of
GTP bound Ras homolog enriched in the brain (Rheb) [121]. Rheb binds to TORC-1
inducing a conformational change which brings the active-site residues into the optimal
position for catalysis [122]. Additionally, Rag GTPases are necessary to recruit mTOR to
the lysosome. In states of high nutrients, the Rag GTPases take on the nucleotide state
whereby Rag A/B is GTP loaded, allowing TORC1 to anchor at the lysosomal membrane
[123]. Once active TORC-1 can bind to and phosphorylate its substrates. As stated earlier,
two important TORC-1 substrates which enhance protein synthesis are P70S6K1 and 4EBP1 [96]. The activation of P70S6K1 in turn phosphorylates additional substrates
facilitating mRNA translation, ribosome biogenesis and the ubiquitination of programmed
cell death 4 (PDCD4) [124]. 4E-BP1 phosphorylation leads to it dissociating from
eukaryotic initiation factor 4E (eIF4E) which promotes 5’-cap dependent mRNA
translation of growth-related genes [125].
Additional TORC-1 targets have been identified leading to increases in TORC-1
activity and/or translation. Proline-rich Akt-substrate of 40kDa (PRAS40), a component of
TORC-1 functions to inhibit TORC-1 kinase activity [126]. Oshiro and co-workers
determined that TORC-1 can phosphorylate PRAS40 at serine 183 both in-vitro and invivo, leading to the dissociation of PRAS40 from RAPTOR [127]. Therefore, TORC-1
may be able to regulate its own kinase activity by modulating the phosphorylation of
PRAS40. TORC-1 was also shown to phosphorylate La-related protein (LARP1) which
was found to be a repressor of 5’ TOP mRNAs [128]. As discussed earlier, 5’TOP mRNAs
encode for ribosomal proteins and other elongation factors needed for growth dependent
translation [129]. Another target of TORC-1 is the master regulator of hypoxia, HIF-1α
[130] which regulates the expression of genes related to anaerobic metabolism,
intracellular pH, and angiogenesis [131]. HIF-1α’s role in skeletal muscle hypertrophy is
not well understood, studies have shown it may be important for skeletal muscle recovery
after eccentric exercise [132].
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An exciting new area in the regulation of skeletal muscle growth involves small
metabolite activation of anabolic pathways. While not part of my dissertation, I took part
in a study that explored how metabolism changes during skeletal muscle hypertrophy. It
was found that during mechanical induced overload, the pentose phosphate pathway (PPP)
is upregulated through an increase in the gene expression of glucose 6 phosphate
dehydrogenase (G6PD) [133]. Although not entirely clear, we speculate that this increase
in the PPP increases the production of NADPH which helps to combat oxidative stress that
accompanies muscle growth and augment nucleotide synthesis. In agreement with our
findings, Hoshino and co-workers demonstrated that high-frequency electrical stimulation
of C2C12 myotubes resulted in a significant increase in PPP enzymes in addition to
NADPH [134]. It appears that during hypertrophy, striated muscle re-wires metabolism to
focus on nucleotide synthesis, a finding not well established in the skeletal muscle field. In
support of metabolic reprograming contributing to skeletal muscle adaptions, Reddy and
co-workers found that during exercise, succinate becomes protonated, allowing it to exit
the skeletal muscle via the monocarboxylate transporter 1. The succinate was found to bind
to succinate receptors on adjacent muscle cells and non-muscle cells, facilitating
improvement in endurance exercise, differential expression in extracellular matrix (ECM)
proteins and inflammatory proteins [135].
These alternative pathways suggest a highly complex and integrated network of
signaling pathways that could operate with or independent from mTORC1 signaling.
Ongoing research in the field of skeletal muscle hypertrophy strives to further define these
novel mechanisms as they represent potentially new targets for therapeutic interventions.
Mechanisms of Skeletal Muscle Atrophy
Skeletal muscle atrophy is not simply the reverse of anabolic signaling. Muscle has
distinct cellular pathways that control protein degradation leading to a reduction in both
sarcomeric and non-myofibrillar proteins as well as decreases in protein synthesis in some
systemic wasting diseases. Atrophy occurs in a wide range of conditions such as disease,
disuse, denervation, aging, starvation and overtraining [136, 137]. A major outcome of the
reduction in muscle mass is a concomitant decrease in muscle strength, which if significant
enough, can lead to a reduced quality of life and exacerbates poor health outcomes [138,
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139]. Using a microarray analysis of mice in various muscle wasting conditions, Leker and
co-workers identified 120 common genes, referred to as “atrogenes”, that responded to the
different muscle wasting models [140]. Notably, these authors found consistent expression
of classic “atrogenes” and unexpectedly observed reductions in collagen synthesis and
mitochondrial ATP synthesis [140]. The unloading of skeletal muscle through the use of a
cast or hind limb suspension apparatus, provide highly effective methods to induce atrophy
[141-144] and have been utilized to mimic space flight conditions. However, it is important
to note that comparing immobilized and suspension models to space flight resulted distinct
patterns of atrogene expression [145]. This finding demonstrates that aspects of the
underlying mechanism of atrophy is specific for the form of atrophy induced by unloading,
disuse or the weightlessness of space.
The ubiquination of proteins by E3 ligases, autophagy mediated autophagosomal
and lysosomal recycling of cellular proteins are the major mechanism use to degrade
protein during atrophy [146]. In 2001, two groups independently reported that transcript
levels encoding the E3 ubiquitin ligases Muscle RING Finger 1 (MuRF1, Trim63) and
Muscle Atrophy F-box (MAFbx, atrogin 1) were increased in response to muscle atrophy
[147, 148]. These proteins act to ubiquinate selective substrates and target them for
proteasomal degradation [148]. Studies have determined that these E3 ligases have a role
in some types of atrophy but are not conserved in all atrophic conditions [149]. For
example, MuRF1 null mice were shown to be protected against 14 days of dexamethasone
induced atrophy and single leg immobilization but not nutritional deprivation or 21 days
of space flight [145, 150]. These findings suggest the possibility that there are other, less
well-known ubiquitin ligases, that might have a role in skeletal muscle atrophy. Cohen and
co-workers found that the tripartite motif-containing protein 32 (Trim32) another RING
finger ubiquitin ligase, is required for the loss of thin myofilaments including, actin,
actinin, tropomyosin and desmin during fasting induced muscle atrophy [151]. TNF
receptor-associated factor 6 (TRAF6) another E3 ubiquitin ligase, promotes the
ubquination of MyHC proteins [152]. Paul and co-workers determined that skeletal muscle
specific TRAF6 knock mice had significantly less muscle atrophy compared to controls in
a denervation model [152]. The reduction in muscle loss was shown to be associated with
a decrease in the activity of kinases (JNK, p38 MAPK and AMPK) that are linked to muscle
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atrophy and a reduction in NF-κβ [152]. The E3 ligases neural precursor cell expressed
developmentally down regulated protein 4, (Nedd-4), from the HECT family of ligases,
was found to play a role in denervation induced muscle atrophy [153]. Specifically, Nedd4
deletion attenuated Type 2a muscle fiber atrophy in the gastrocnemius. These authors
identified possible Nedd4 substrates but could not detected differences in MTMR4, FGFR1
and Notch-1 ICD between the Nedd4 knock out and littermate controls [153].
As described in section 1.1.3, activation of Akt leads to the subsequent activation of
TORC-1 and downstream regulation of protein synthesis. An additional role of Akt is to
phosphorylate a family of forkhead box O (FOXO 1, 3 and 4) transcription factors, which
inhibits their translocation into the nucleus [95]. Sandri and co-workers determined that
FOXO3 promoted atrogin-1 transcription by binding to the 5’ untranslated region of the
TATA box and promoter region of the atrogin-1 gene [154]. FOXO3 was shown to activate
the lysosomal and proteasomal pathways, increasing protein degradation in myotubes. This
was initiated by FOXO3 regulation of myotube autophagy and increased expression of
atrogin-1. MuRF1 and the autophagy related genes Bnp3, Bnip3L, Gabarpl and Ulk1 were
also shown to be targets of FOXOs demonstrating a wide range of proteins that are
regulated by FOXOs during muscle atrophy [155].
Another regulator of skeletal muscle mass is myostatin, a member of the
transforming growth factor beta (TGF-β) super family. In 1997, McPherron and coworkers

discovered

a

novel

TGF-β

family

member

which

they

called

growth/differentiation factor-8 (GDF-8/myostatin). Homozygous GDF-8 mutant mice
were shown to be roughly 30% larger compared to heterozygous and wild type controls.
This increase in mass was related to substantial increases in both skeletal muscle
hypertrophy and hyperplasia [156]. In skeletal muscle, myostatin is first produce as a
precursor called prepromyostatin which subsequently becomes cleaved to promyostatin
before being released in the mature form [157]. Working in an autocrine or paracrine
fashion, myostatin binds to muscle cell surface receptors called associated activin type 2A
and 2B (ActaR2A/2B) initiating the recruitment of the type 1 receptor tyrosine kinases,
activin-like kinase-4 and 5 (ALK4,5), that go on to phosphorylate Smad 2 and 3 [157]. The
phosphorylation of Smad2 and Smad3 promotes binding to Smad4, forming a
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heterocomplex, which translocates to the nucleus where it binds to various transcription
factors, coactivators and repressors to influence gene expression [158]. Injecting mice with
myostatin resulted in significant decrease in muscle weight and fiber CSA, demonstrating
its role in enhancing muscle wasting [159]. Goodman and co-workers determined that
Smad3 positively influenced the transcription of Atrogin-1 and suppressed the activity of
PGC-1α [160]. Over expression of Smad3 in skeletal muscle also resulted in a decrease in
muscle fiber CSA and protein synthesis [160]. Pharmacological blocking of the ActR2B
receptor with a soluble ActR2B-Fc significantly reversed the loss of lean mass and muscle
weight compared to controls in a mouse model of cancer cachexia [161]. Inhibiting the
action of myostatin with follistatin in adult mice resulted in significant skeletal muscle
hypertrophy [162]. Therefore, these studies demonstrate that myostatin acts a powerful
negative regulator of skeletal muscle growth.
Other mechanisms of muscle loss have been reported to be driven by systemic
inflammation. Chronic inflammation leads to an increase in pro-inflammatory cytokines,
which compromises muscle protein synthesis and elevates the ubiquitin-proteasomal
system and autophagy [163]. Systemic inflammation initiated by the administration of
lipopolysaccharide (LPS), led to a significant reduction in muscle protein synthesis and
RNA content [164] and a significant increase in TNF-α, IL-1, IL-β, Il-6, CXCL1,
RANTES, G-CSF and NF-κβ [165]. Chronic low-grade systemic inflammation that can be
seen with aging, also interferes with protein synthesis as observed in both rodents and
humans [166, 167] and Draganidis et al. (2021) (not yet in endnote). These data suggest
that during aging and disease, the resulting increase in pro-inflammatory cytokines increase
catabolism resulting in skeletal muscle atrophy.
The Microbiome
The human microbiota comprises all the bacteria, archaea, viruses, phages, yeast,
fungi and protozoa on and within the body, including the skin, mouth, nasal cavities,
urogenital tract, and digestive system. [168]. Currently, over 90,000 metagenomes have
been assembled [169], showcasing the immense complexity and enormous potential
interactions between the microbiota and host. The intestinal environment creates unique
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niches for microbes to aid in the digestion of macronutrients, micronutrients and other
foreign substance consumed by the host and it is thought the gut microbiome harbors the
largest number of microbial genes [170]. Moving forward in this dissertation, the term
“microbiome” will refer to the bacteria component, unless otherwise stated. The
microbiome was first thought to be acquired at the moment of birth, whether the infant was
delivered vaginally or by caesarian section, resulted in unique microbial signatures [171].
When sequencing the meconium (the infant’s first intestinal discharge), Gosbales and coworkers determined it was not sterile and in fact reflected the intrauterine microbiome. This
was conducted in a small sample of mothers and infants (n=7), but it does present data
suggesting the initial acquirement of the microbiome occurs in-utero [172]. The subsequent
modality of birth may then influence the infant native microbiome. The infant’s developing
microbiome, postpartum, is subject to many influencing factors such as diet, environment,
stress, hygiene and antibiotics [173]. The stabilization of the infant microbiome begins to
occur between years one to three and many of the early colonizers reflect vertical
transmission from mother to infant [174, 175]. Recently, Ferretti and co-workers tracked
the microbiomes of infants and their mothers from one day postpartum to four months. The
infant’s gut microbiome at one day postpartum had 49.3% unique species that were not
identified in the mother. By four months, the unique species in the infant declined to 38.9%
[176]. Additionally, the infant’s microbiome at day one postpartum, had very high strain
level heterogeneity (roughly 6.1-fold more polymorphisms compared to the mother). The
intra-strain level diversity begins to decline by one month, suggesting a high degree of
selection takes place during the initial postpartum period [176]. Finally, this study showed
that bacterial strains acquired vertically from the mother were not replaced by another
conspecific strains, concluding that vertically transmitted strains are better suited for
colonization [176].
The early colonization of the microbiome is a dynamic process that is constantly
adapting as the infant becomes exposed to their new environment. The adult microbiome
is also sensitive to perturbations. Environmental stimuli, such as diet, exercise, xenobioitcs,
stress and trauma [177-182] modulate the composition of the microbiome, creating a
complex balance between microbes that are beneficial for the host and those that may
contribute to disease [183]. Microbes have been shown to generate numerous metabolites
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(reviewed in sections 1.2.2-1.2.6) with beneficial and/or detrimental roles in cancer,
autism, Parkinson’s, obesity, heart, lung, and bowel disease [184-191]. As the microbes
respond to environmental cues, they alter their function which may aid the host to adapt,
or conversely contribute to the development of a disease state. Das and co-workers
determined in response to excess dietary iron intake, the gut microbiota produced two
metabolites (reuterin and 1,3-diaminopropane (DAP)) which helped to lower host iron
levels by suppressing Hif2α [192]. These results demonstrate that the microbiome can
sense perturbations occurring in the host and effectively respond via specific metabolites.
It is crucial to understand how alterations in microbial composition reflect changes in its
functional output and what consequences this can have on the host.
The Gut Microbiome Skeletal Muscle Axis
In 2007 Bäckhed and co-workers determined that the gastrocnemius muscle of germfree mice, mice without any microorganisms, had significantly higher expression of
phosphorylated acetyl-CoA carboxylase, AMP-activate protein kinase and carnitine
palmitoyl transferase compared to mice with an intact microbiome [193]. These results
implied that skeletal muscle from germ-free mice had a higher propensity to oxidize fatty
acids. This finding is the first compelling evidence to show the gut microbiome can
influence skeletal muscle metabolism. Following their initial work, Everard and coworkers found that feeding obese mice with a prebiotic diet resulted in a significant
increase in lean body mass and normalized muscle wet weight compared to control obese
mice [194]. Additionally, Bindles and co-workers determined that supplementing mice
with Lactobacillus reuteri and Lactobacillus gasseri significantly lowered the expression
of Atrogin-1, MuRF1, LC3 and Cathspin L in both the gastrocnemius and tibilais anterior
muscles in a model of cancer [195]. Supplementing mice with the probiotic Lactobacilli
plantarum (L. plantarum) for six weeks significantly increased grip strength, swimming
time to exhaustion, normalized muscle weight and the percentage of Type 1 fibers [196].
Yan and co-workers then provided evidence that the gut microbiome could regulate
skeletal muscle fiber-type composition [197], expanding the ways in which skeletal muscle
can be influenced by the microbiome. Fielding and co-workers transferred the microbiome
from high functioning (HF) and low functioning (LF) older adults into germ-free mice and
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found that the recipients of the HF microbiome had significantly increased hand grip
strength compared to the LF recipients [198]. The results from these pioneering studies
indicated that the gut microbiome could regulate skeletal muscle metabolism, atrophy and
fiber-type composition. The underlying mechanism through which the gut microbiome
affects skeletal muscle remains to be determined.
In one of the most comprehensive studies which examined the relationship between
the microbiome and skeletal muscle, Lahiri and co-workers found skeletal muscle from
germ-free mice was atrophic compared to specific pathogen free (SPF, mice without any
known pathogens)[199]. Germ-free mice had significantly higher expression of atrogin-1,
MuRF-1 and FoxO3, and significantly lower expression of MyoD and MyoG compared to
SPF mice. Germ-free mice were also found to have significantly lower expression of genes
related to oxidative and glycolytic metabolism and higher amounts of intramuscular
glycogen [199]. These same authors showed that the administration of short chained fatty
acids (SCFA, bacterial metabolites derived from the fermentation of fiber) rescued the
muscle atrophy observed in germ-free mice, providing strong support for the idea that
metabolites produced from the gut microbiome could regulate skeletal muscle mass [199].
These results also suggest that the microbiome modulates the development of skeletal
muscle as shown by the atrophic phenotype and lower expression of MyoD and MyoG.
Although not the focus of this dissertation, the importance of the microbiome during postnatal development is an important consideration.
Most recently, the SCFA butyrate, was found to mitigate skeletal muscle atrophy in
diabetic (db/db) mice [200]. To determine a mechanism, Tang and co-workers found that
butyrate activated the extracellular free fatty acid receptor 2 (Ffar2), which led to an
increase in the phosphorylation of PI3K-AKT-TORC-1 pathway. This ultimately increased
muscle protein synthesis and decreased reactive oxygen species and autophagy [200]. In
support of skeletal muscle regulation by butyrate, Ly and co-workers used Mendelian
Randomization (MR) to estimate skeletal muscle mass and associated gut microbiomes in
menopausal females. Two butyrate producing microbes were found to be

positively

correlated with skeletal muscle index (a measure of appendicular lean mass/body mass)
[201]. Furthermore, a one-way MR analysis revealed a significant association between
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appendicular lean mass and butyrate producing microbial pathways [201]. These data
highlight that SCFAs, especially butyrate, can regulate skeletal muscle mass and be a
potential therapy to treat muscle wasting.
In addition to the regulation of skeletal muscle plasticity, evidence suggests the
microbiome may also contribute to exercise performance. Initially, Hsu and co-workers
determined that germ-free mice have significantly reduced exercise capacity compared to
SPF controls [202]. Supplementation with the probiotic L. plantarum significantly
improved endurance performance in a group of highly trained triathletes as well as mice
[203, 204]. Scheiman and co-workers determined that elite endurance athletes possess a
microbe Veillonella atypica, which contributed to enhanced endurance performance.
Transplanting V. atypica into mice led to significantly greater time to exhaustion compared
to mice receiving a Lactobacillus bulgaricus control [205]. These authors also
demonstrated that supplementing mice with the SCFA propionate also increased time to
exhaustion [205]. In a case study, Grosicki and co-workers determined that Veillonella
abundance was increased 143-fold in a world class ultramarathon runner after completing
a 100-mile race [206]. Jaago and co-workers looked at how endurance training modifies
the gut microbiome composition supplemented with a high-fiber supplement in an 18-yearold male champion rower during an eight-month period of heavy training. This study
provided interesting data highlighting how training itself modulates the composition of the
microbiome, specifically decreasing the alpha-diversity. The addition of a high-fiber
supplement with heavy training resulted in an increase in alpha-diversity [207]. It seems
that exercise creates a very specific microbial composition when all other factors are left
unchanged. The addition of specific nutrients creates a unique microbial signature, that
could be exploited to enhance performance and/or recovery. It is not known if the
compositional changes provided in this study resulted in enhanced exercise performance.
Future research will need to determine the combinatorial effects of exercise and nutrition
on functional changes in the microbiome that could act as ergogenic aids to enhance
performance.
Early studies demonstrated a connection between the microbiome and hypothalamic
pituitary axis, suggesting a connection between the host stress-response and commensal
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microbes [208]. As the result of continued research , the microbiome is now considered an
endocrine organ, as it can synthesize and release chemical factors into the systemic
circulation [209]. Many metabolites of the gut microbiome have been associated with host
metabolism, behavior, autoimmunity, and stress [210-212]. Additionally, the microbiome
can influence hormone levels through their own network of genes that metabolize host
secreted hormones [213]. Weger and co-workers found that the gut microbiome was
necessary for regulating sex-specific diurnal fluctuations in serum testosterone, estradiol
and growth hormone which was required for sexual maturation [214]. Furthermore, host
hormones may modulate the composition of the microbiome, suggesting a bi-directional
crosstalk between the microbiome and host [215]. The cross-talk between the microbiome
and endocrine system poses another avenue by which gut microbes could influence skeletal
muscle plasticity and performance, either by directly contributing to systemic adaptions or
indirectly by influencing maturation.
In groundbreaking work from Markel and co-workers, germ-free male and female
mice had significantly lower serum testosterone levels compared to their SPF counterparts
[216]. Remarkably, transferring the microbiome from a male mouse into young female
recipients significantly increased serum testosterone levels [216]. Growth hormone (GH)
and insulin like growth factor-1 (IGF) levels also seem to be sensitive to the microbiome,
as it was found that germ-free mice had significantly lower levels compared to
conventionally raised mice [214, 217]. Monocolonizion with L. plantarum of germ-free
mice resulted in a significant increase in GH, IGF-1, and IGFBP-3 at 28 and 56 days after
birth [217]. Monocolonized mice had a 14% increase in the rate of growth that resulted in
germ-free mice weighing 52% more than SPF control mice [217]. Although skeletal
muscle was not analyzed, the findings from Yan and co-workers are consistent with
previous studies showing that the microbiome increased systemic IGF-1 and IGFBP3
levels, which stimulated bone formation [218]. The microbiome-IGF axis was mediated by
SCFAs, providing further evidence that microbial-derived metabolites can regulate host
hormone levels [218].
Additional evidence for bidirectional crosstalk between the gut microbiome and
endocrine system was shown with castrated cattle that have an altered microbiome
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compared to the non-castrated controls. The castrated cattle were found to have lower
testosterone and greater adiposity with significant differences in their microbiome
compositions[219]. When mice received a fecal transplant from either castrated or sham
operated male mice, there was a significant decrease in serum testosterone and significant
increase in fat deposition in the mice who received the microbiome of castrated mice [219].
These findings have implications for exercise adaptations and human performance given
the ability of anabolic hormones such as testosterone and GH to promote greater skeletal
muscle mass. Given the endocrine-microbiome axis, manipulation of microbiome
represents a potentially new ergogenic aid to enhance athletic performance.
As mentioned earlier, an area of microbiome research is the determining the effect
of microbial-derived metabolites on host physiology. Deng and co-workers showed the gut
microbiome produces numerous metabolic products including, amino acids, central carbon
metabolites, dinucleotide cofactors, vitamin B5 and GABA [220]. The vast number of
metabolites generated from the microbiome offers novel mechanisms of host cellular
regulation which could result in new therapeutics or biomarkers for disease. Interestingly,
a single gut microbial metabolite can be viewed as beneficial or toxic depending on a
variety of contributing factors. The next sections will provide a brief overview of
microbial-derived metabolites and their effect on the host physiology.
Gut Microbial Metabolites
Microbial metabolites have been broadly classified as short chained fatty acids
(SCFA), secondary bile acids, amino acids, neurotransmitters and lipids [221-223].
Microbial metabolites have been implicated in numerous disease states such as obesity,
cancer, autism, Parkinson’s, depression, anxiety, inflammatory bowel disease, heart and
lung disease [189-191, 193, 224, 225]. Microbial metabolites have also been shown to
play a role in normal host metabolism; for example, the gut microbiome contributes to the
production of NAD+ a major cofactor involved in redox metabolism that is essential for the
removal of acetyl groups from their substrates [226, 227]. Our understanding of the causal
role between microbial metabolites and host physiology remains in its infancy but
emerging evidence suggests these metabolites contribute to host health [211]. Microbially
derived metabolites may also be represent unique biomarkers for certain pathologies as
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Gyu Oh and co-workers determined that 17 different gut microbial derived metabolites
could predict non-alcoholic liver fatty acid disease [228]. The following sections will
outlie the major microbial metabolites and present evidence on how they could regulate
skeletal muscle physiology.
Short-Chained Fatty Acids (SFCA)
SCFA differ by the number of carbons that make up the backbone of each molecule;
formate (C1), acetate (C2), propionate (C3), butyrate (C4) and valerate (C5). SCFAs are
the most well-studied bacterial metabolites in microbiome research [229, 230]. SCFAs are
produced through bacterial fermentation of carbohydrates mainly through the five
metabolic pathways: 1) Wood-Ljungdahl pathway (Acetate) [231]; C2) Acrylate Pathway
(Propionate); C3) Succinate Pathway (Propionate) [232]; 4) Propanediol Pathway
(Propionate) [232]; and 5) Butyrate Synthesis Pathways (Butyrate), in which L-glutmate,
carbohydrates, and succinate are the precursors [233, 234]. SCFAs are primarily utilized
by colonic epithelial cells but can be readily detected in the human blood at concentrations
of roughly 70-173, 4-5 and 4-8 µmol/l for acetate, propionate and butyrate, respectively
[235, 236]. SCFAs participate in numerous signaling cascades, pathologies and recently
have been found to modulate the epigenetic landscape of various tissues [237]. The role of
SCFAs on host disease are continually emerging and growing evidence supports that these
metabolites modulate a wide range of pathologies such as inflammation, Alzheimer’s,
Parkinson’s, obesity, and some forms of cancer [238-241]. Importantly, SCFAs have been
suggested to participate in cross-talk with skeletal muscle and the cardiovascular system,
proposing a direct link between the microbiome metabolites and striated muscle [200, 242,
243].
Mechanistically, SCFAs have been shown to act in diverse ways which could potentially
enhance the function of skeletal muscle. SCFAs act as ligands for G-coupled protein
receptors (GCPR), specifically the GCPRs knowns as free fatty acid receptors (FFAR 14), with FFAR 2 and 3 being the most widely studied [244]. SCFAs have also been
suggested to increase muscle grip strength, and muscle size [199], increase the abundance
of Type 1 muscle fibers [245], increase the expression of phosphorylated AMP-activated
protein kinase (AMPK) in both the gastrocnemius muscle and liver [246, 247] and improve
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glucose/insulin metabolism [248]. Recent research highlights that the SCFA butyrate could
prevent skeletal muscle atrophy [200] making butyrate a potentially valuable therapeutic
for conditions where there is a high-degree of muscle loss. Future research needs to
establish the mechanism by which SCFA act in skeletal muscle to modulate the anabolic
and catabolic pathways.
Microbially produced SCFAs are potentially a major metabolite that could directly
or indirectly regulate skeletal muscle by modulating muscle growth and and/or function
and they have been shown to improve exercise performance by serving as an alternative
energy source. SCFAs can be used as an energy source with the complete oxidation of
acetate, butyrate and propionate yielding 10, 27 and 18 ATP/M, respectively [249].
Okomoto and co-workers found that acetate supplementation significantly improved
exercise capacity in mice after antibiotic depletion of the gut microbiome [250]. Scheiman
and co-workers performed intrarectal administration of propionate in mice, which resulted
in a significant increase in treadmill run time [205]. These studies were unable to
mechanistically describe exactly how the SCFAs improved running performance, but
Scheiman and co-workers hypothesized the muscle might be utilizing propionate for fuel
[205]. Data from human studies supports the findings from animal studies that SCFAs
contribute to exercise performance as seen by Yu and co-workers who demonstrated higher
enrichment of SCFA producing microbes in individuals with higher exercise capacity
[251]. Furthermore, Allen and co-workers determined that exercise caused a significant
increase in SCFAs producing bacteria in lean but not obese individuals [180]. Moreover,
the exercise-induced increase in SCFA producing microbe abundance returned to baseline
levels once training ceased [180], demonstrating that exercise promotes the growth of
SCFA producing bacteria.
Exciting evidence is emerging that suggests SCFAs can function as inhibitors of
histone deacetylases (HDACs) [252] and provide acetyl groups that directly modify
histones [253]. These results support the exciting idea that the microbiome participates in
gene regulation through modulating the epigenetic landscape of host DNA. Recently
epigenetic regulation of enhancer and MYC- associated areas within ribosomal DNA was
found to occur in response to resistance exercise [254], providing evidence that gene
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modifications are important in skeletal muscle adaptions to exercise. Although to date no
study has directly linked the gut microbiome and skeletal muscle epigenetic modifications,
it seems plausible this could be a possible mechanism as it has been shown in other tissues
[237].
Bile Acids
Bile acids are products of cholesterol metabolism synthesized in hepatocytes and play an
important role in the absorption of dietary lipids and lipid soluble vitamins [255]. The two
main bile acids are cholic acid (CA) and chenodeoxycholic acid (CDCA). CA and CDCA
are rendered bile salts upon conjugation to either glycine or taurine, and then are stored
in the gallbladder until cholecystokinin stimulates their release [256]. In addition to their
role on lipid metabolism, bile acids serve as ligands for three nuclear receptors 1) Farnesoid
X-receptor, 2) vitamin D receptor and 3) the GCPR, TGR5 [257]. Roughly 95% of bile
salts are reabsorbed via the apical sodium-dependent transporter (ASBT) with the
remaining bile salts susceptible to modification by the gut microbiota [257]. Microbes
which possess the bile salt hydrolase enzymes can deconjugate the primary bile salts by
removing the glycine or taurine amides. Microbial modifications continue as bacteria with
bile acid-inducible operon (bai) genes can dehydroxylate the deconjugated bile acids into
secondary bile acids [258]. In addition to modifying bile salts, the microbiome has been
shown to alter the expression of genes involved with bile acid synthesis and transport in
both the ileum and liver [259]. In this way, the microbiome can adjust the production of
secondary bile acids by regulating the synthesis of bile acids [258]. Bile acids themselves
have also been shown to influence microbial composition of both gram negative and
positive bacteria [260] demonstrating a bidirectional interaction between microbes and bile
acids.
Bile acids that have been modified by the gut microbiome such as lithocholic acid
(LCA) and deoxycholic acid (DCA) have been shown to be an agonist for the G-protein
coupled receptor, TGR5 [258]. Chaudhari and co-workers found that the microbiome
dependent LCA drove the expression of cholic-acid-7-sulfate which was identified as
another agonist for TRG5 receptors [261]. Thus, microbial modified bile acids can directly
or indirectly activate TGR5 which is known to control expression of key genes involved in
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metabolism and energy expenditure [262]. TGR5 is expressed in skeletal muscle, raising
the possibility that microbial derived bile acids could signal to skeletal muscle via TGR5.
Studies which have investigated the role of TGR5 in skeletal muscle reported that its
activation promotes skeletal muscle hypertrophy, differentiation and glucose homeostasis
[263-265]. Abrigo and co-workers recently found that supplementing C2C12 myotubes
with DCA resulted in an atrophic effect by significantly increasing the expression of the
E3 ubiquitin ligases, atrogin-1 and MuRF-1 [266]. These contrasting results are not fully
understood and need to be further validated. None-the-less, these findings highlight that
bile acids do have the ability to directly activate TGR5 and cause changes in skeletal
muscle size.
Amino Acids
The ability of amino acid supplementation to augment skeletal muscle hypertrophy has
been well-documented over the last 20 years [267]. Studies have demonstrated that the
ingestion of amino acids, primarily the branched chain amino acids (BCAA, leucine,
isoleucine and valine), enhances protein synthesis resulting in increased skeletal muscle
growth [268, 269]. Additionally, the amino acid glutamine was found to support the
immune system resulting in significantly lower infection rates after completion of a
marathon [270]. While amino acids are produced via host metabolism (non-essential amino
acids) or acquired through the diet (essential amino acids), stable isotope resolved
metabolomics (SIRM) has revealed that the gut microbiome can synthesize 36 different
amino acids [220]. These experiments were carried out in an ex-vivo fashion, hindering the
ability to determine if these amino acids are taken up by the host. Choi and co-workers
demonstrated that microbial fermentation of BCAA resulted in the production of branched
chained fatty acids (BCFAs) [271]. These BCFAs were found to promote hepatic insulin
resistance, with no effect on skeletal muscle [271].
When Lui and co-workers exercise trained individuals for 12 weeks, they found
that those who improved their glycemic responses had increases in SCFA production and
BCAA catabolism. Contrastingly the non-responders had increased levels of
phenylalanine, indole, histidine, leucine, and p-Cresol. Administration of microbial derived
BCAA exerted a pro-growth effect in Drosophila by activation of TORC-1 [272]. There
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are many factors to consider when looking at the role of amino acid on the microbiome or
microbial produced amino acids effect on the host. More studies need to determine what
factors may be linked to disease or improvements in host health. It appears that microbially
derived amino acids or metabolic derivatives can activate TORC-1. In the context of
muscle growth, transient increases in TORC-1 activation mediated by the microbiome
would be beneficial, potentially enhancing any pro-growth stimulus. Continuous activation
of TORC-1 over time may result in determents to skeletal muscle such as impaired glucose
handling, anabolic resistance, or autophagy.
Tryptophan (Trp) is the largest amino acid by molecular weight, with a complex
structure containing an indole and a bicylic ring consisting of a benzene and pyrrole linked
to the alpha carbon amino acid through a methylene group [273]. Trp is the least abundant
amino acid, with a frequency of roughly 1.4% (leucine by comparison is 9%) [274] but
because of its complex structure it serves as an excellent source for host-microbiome
interactions [223]. Trp has several different fates in the gastrointestinal tract It can be
metabolized by host cells and microbes resulting in the production of serotonin, kynurenine
and ligands for aryl hydrocarbon receptors (AhR) [275]. Microbial metabolism of Trp
results in the production of indole and indole derivative compounds; tryptamine,
indoleacetic acid (IAA), indole propionic acid (IPA), indolelactic acid (ILA) and
indoleacrylic acid (IA) [223, 276]. The direct effects of microbial derived indoles on
skeletal muscle is not known, however they have been found to attenuate inflammation
[277, 278]. If these metabolites play a role in mitigating inflammation, they may modulate
skeletal muscle plasticity by influencing immune cells within the muscle, such as
macrophages, which are known to have an important role of muscle adaptation to exercise
[279].
As mentioned above, Trp can also be shuttled to the kynurenine pathway via the
rate limiting enzyme IDO. The kynurenine pathway produces many metabolites known as
“kynurenines” with the end product being nicotinamide adenine dinucleotide (NAD) [280].
IDO expression has been previously shown to be dependent on the microbiome, as the
transcript is not found in germ-free mice [281, 282]. Thus, the generation of kynurenines
could be heavily influenced by the microbial regulation of IDO. Interestingly, elevated
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expression of PGC-1α1 in exercising muscle was associated with increased expression of
kynurenine aminotransferases (KAT) which catalyze the conversion of kynurenine to
kynurenic acid [283]. Using carbidopa (used to inactivate a co-factor for KAT activity),
Agudelo and co-workers determined KAT inhibition resulted in decreased running
performance and ex-vivo muscle strength in mice [284]. The increase in kynurenic acid
generates glutamate as a byproduct which is then shuttled from the cytosol into the
mitochondria where it participates in the reduction of NAD+ to NADH through the malate
aspartate shuttle [284]. From this work it is apparent that exercised muscle can take a toxic
chemical and convert it to a beneficial compound that can enhance performance. It remains
to be determined if the gut microbiome contributes to an increased utilization of kynurenine
by skeletal muscle by modulating the expression of IDOs. This line of inquiry represents
an attractive area of research linking the gut microbiome-skeletal muscle-brain axes.
Lipids
One of the fundamental building blocks of the cell is lipids, which consist of
thousands of different species, accounting for a diverse set of structural and signaling
molecules [285]. Lipids represent a major fuel source to power prolonged endurance
exercise, provide energy during periods of low food intake, contributes to thermogenesis
and plays a role in the regulation of glucose handling [286-288]. Lipids are primarily
synthesized in the endoplasmic reticulum, Golgi apparatus and to a lesser extent
mitochondria and peroxisomes [289, 290]. Recently, Brown and co-workers demonstrated
that the gut microbe Bacteroides thetaiotaomicron (B. theta) contributed to host
sphingolipid bioavailability and were negatively correlated with intestinal inflammation
[291]. In addition, Bacterioides sphingolipids were significantly decreased during active
periods of ulcerative colitis and Crohn’s disease [291]. This work was followed up by
Johnson and co-workers who further demonstrated that sphingolipids produced from B.
theta could be metabolized by host epithelial cells [222]. These same authors determined
that supplementation with B. theta could modulate host hepatic ceramide production [222],
suggesting that bacterial derived lipids contribute to the bioavailability of host lipids. Most
recently, Rienzi and co-workers showed that hepatic sphingolipid levels were modulated
by the gut microbiome mass in mice, but not plasma fatty acids [292]. Although specific
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microbes were not identified in this study these results suggest that the microbiome
regulates lipid production with a high degree of specificity. Ceramide is a precursor to
complex sphingolipids and has been shown to contribute to insulin resistance [293], cancer
cachexia [294], and associated with elevated risk for adverse cardiovascular events [295],
implying a negative role of ceramides in health and disease. Interestingly, ceramide levels
in skeletal muscle are elevated after exercise and the ceramide derivative, sphinosine-1phosphate, was shown to reduce muscle fatigue in isolated mouse extensor digitorum
longus muscle [296] and is important for maintaining mitochondrial respiration in
cardiomyocytes [297].
Conclusion
Skeletal muscle is an extremely well-organized and complex tissue, which contributes to
many aspects of life. In addition, the gut microbiome provides another intricate system
that help to shape the host through development, aging and certain pathologies. Research
is now demonstrating how the microbiome regulates skeletal muscle in both health and
disease. While the details remain to be defined, the emerging evidence provides strong
support for microbial- derived metabolites entering systemic circulation and subsequently
directly affecting the cellular activity of skeletal muscle. Providing a complete
understanding of how the microbiome could shape muscle both in terms of anabolic and
catabolic signaling pathways will allow researchers to design new strategies to combat
the loss of muscle, rescue developmental disorders or provide ergogenic aids enhance
athletic performance.
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CHAPTER 2.

DYSBIOSIS OF THE GUT MICROBIOME IMPAIRS MOUSE SKELETAL MUSCLE
ADAPTION TO EXERCISE (PUBLISHED IN JOURNAL OF PHYSIOLOGY, SEPTEMBER 2021)

Introduction
Skeletal muscle is one of the largest organs of the body representing close to 50% of total
body mass. Skeletal muscle functions as a biological motor that allows for the production
of work, heat generation, regulation of blood glucose and as a reservoir of amino acids [3,
298-301]. A remarkable quality of skeletal muscle is the ability to alter its physical
characteristics in a specific manner in response to regular bouts of exercise. The cellular
and molecular mechanisms that underlie this adaptive ability are an area of intense
research given the importance of skeletal muscle to overall health.
There is exciting evidence to suggest the gut microbiome may play a role in
regulating skeletal muscle mass and function. In a pioneering study, Bäckhed and coworkers reported skeletal muscle of germ free (GF) mice (completely devoid of any
commensal bacteria) had significantly higher levels of phosphorylated AMPK and acetylCoA carboxylase compared to specific pathogen free (SPF) mice, indicating GF mice
rely more heavily on fatty acid oxidation as an energy source and might explain why GF
mice are more resistant to obesity [193]. Additionally, skeletal muscle of GF mice is
atrophic compared to SPF mice and inoculating GF mice with microbiota was able to
restore muscle mass [199]. Exercise has been shown to modulate the composition of the
microbiome with specific microbes associated with enhanced exercise capacity [205, 206,
302, 303]. Exercise-induced changes in the gut microbiome were reported to have
systemic benefits, indicating the microbiome of an exercise trained host is protective
against a range of different pathologies [304-307]. These findings have generated great
excitement in the exercise physiology field as well as other fields of research seeking to
utilize the microbiome to treat diseases such as cancer, depression, obesity, Parkinson’s
and autism [188, 189, 191, 193, 308]. A better understanding of the role of the gut
microbiome in skeletal muscle plasticity could ultimately provide new interventions to
treat conditions such as cachexia and sarcopenia, the age-related loss in skeletal muscle
mass and function.

Although there is emerging evidence to support the concept of a gut microbiomeskeletal muscle axis [309-313], there remains a scarcity of studies investigating the
potential role of the gut microbiome in skeletal muscle adaptation to exercise. The
purpose of this study was to test the hypothesis that the gut microbiome is required for
skeletal muscle adaptations to exercise. To test this hypothesis, mice were treated with or
without antibiotics throughout an nine-week progressive weighted wheel running
(PoWeR) protocol which has been shown to induce hypertrophy and a fiber-type shift to
a more oxidative phenotype [314]. Despite the same exercise stimulus, antibiotic-treated
mice had a blunted hypertrophic response and fiber-type shift compared to the untreated
mice. These findings provide the first evidence showing that disruption of the gut
microbiome impairs skeletal muscle adaptation to exercise and suggest the exciting
possibility that microbially derived metabolites have an important role in skeletal muscle
plasticity.
Methods

Mice
Adult (4 months of age), female C57BL/6J mice were purchased from The Jackson
Laboratories (Bar Harbor, ME). Upon arrival, mice were housed 4-5 per cage and
acclimated for one month to allow for the gut microbiome to become stabilized to the
new housing facility [315]. Mice were then randomly assigned to one of four groups
(n=10-11/group): 1) Non-running control untreated (CU), 2) PoWeR untreated (PU), 3)
Non-running control treated with antibiotics (CT) and 4) PoWeR treated with antibiotics
(PT). All non-running control mice were housed individually in a running wheel cage as
the PoWeR mice, except the running wheel remained locked for the duration of the study.
One mouse in the CT group died unexpectedly three days before completion of the study
thus the CT group had n=9. Animals were kept on a 10:14 light cycle with irradiated
chow (Teklad 2918 protein rodent diet) and water ad libitum. Fresh, autoclaved water
with or with antibiotics was provided each week. Food and water consumption were
measured weekly. Cage and bedding were changed each week with dirty bedding from
the previous week pooled for each group and then added to clean bedding in a ratio of 2/3
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clean bedding and 1/3 dirty bedding in an effort to reduce microbial drift during the
course of the study [316].
Antibiotic Treatment
Upon completion of the acclimation period, mice were randomly assigned to a group
(CU, CT, PU or PT), then placed singly into a running wheel cage with antibiotic
treatment initiated for CT and PT groups. Antibiotic treatment was started one week prior
to PoWeR training, designated week 0, to allow for depletion of the microbiome prior to
exercise [317]. Antibiotics were continuously administered via the drinking water and
prepared fresh twice per week. Each time new antibiotics were administered, drinking
volume was collected resulting in fluid consumption measurements taken twice per week.
In the untreated groups, mice received the same autoclaved water, which was changed at
the same time as the antibiotic treated groups. The antibiotic cocktail was modified from
[318, 319] and consisted of 100 µg/ml each of metronidazole (Sigma, M1547), neomycin
(J&K, 557926), and ampicillin (Sigma, A0166) and 50 µg/ml each of vancomycin
(Sigma, V2002) and streptomycin (Life Technologies, 1513783. This antibiotic cocktail
was chosen because it was shown to not cause weight loss and lethargy [319].
Progressive Weighted Wheel Running (PoWeR)
Mice underwent eight weeks of the PoWeR protocol as previously described by our
group; PoWeR training was shown to induce hypertrophy and a fiber-type shift in
muscles of the lower hind limbs [314]. Mice were singly housed in running wheel cages
with free access to the running wheel. Individual running data (km/d) and total running
volume (km) was recorded using ClockLab software (Actimetrics, Wilmette, IL). During
the first week of training, mice ran with an unloaded wheel to allow for acclimation to the
running wheel. After the acclimation period (week 1), weight was loaded onto the wheel
for a training intensity that consisted of 2g during week 2, 3g during week 3, 4g during
week 4, 5g during week 5 and 6 and 6g during weeks 7-9. The weight consisted of 1g
magnets (product no. B661, K&J Magnetics, Pipersville, PA), that were attached on one
side of the running wheel.
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Immunihistochemistry
Immunohistochemistry (IHC) analysis was performed as previously described by us [56,
314] on the soleus and plantaris muscles to determine skeletal muscle fiber crosssectional area, fiber-type composition, and myonuclei abundance. Excised soleus and
plantaris muscles were immediately weighed, with one limb snap-frozen in O.C.T using
liquid nitrogen-cooled isopentane and muscles from the other limb snap-frozen in liquid
nitrogen and then stored in -80°C for biochemical and molecular analyses. Muscle
samples were mounted and cut into 7µm sections. Muscle sections were air-dried
overnight at room temperature. After drying, the sections were incubated in a cocktail of
iso-type specific anti-mouse primary antibodies against myosin heavy chain (MyHC) 1,
MyHC 2a (Developmental Studies Hybridoma Bank, Iowa City, IA) in addition to an
antibody against dystrophin (catalog no. ab15277, Abcam, St. Louis, MO). Type 2b and
Type 2x were not stained and counted based on the lack of staining. For muscle fibertype composition, we combined Type 2b and Type 2x fibers based on their similar
phenotype [320]. Primary antibodies were diluted 1:100 in PBS with slides incubated for
two hours at room temperature, then washed three times in PBS and incubated for 90
minutes at room temperature with the appropriate secondary antibodies at a dilution of
1:250. During the final 10 minutes of the secondary incubation, DAPI (Vector
Laboratories, 1:10,000) was added to counterstain nuclei. Sections were then washed
three times in PBS and mounted using PBS:glycerol solution at a 1:1 ratio. IHC for Pax7+
was performed according to the protocol established by our laboratory [56, 321].
Image Capture and Analysis
IHC sections were captured at 20X magnification using an upright fluorescence
microscope (AxioImager M1, Zeiss, Oberochen, Germany). Quantification of skeletal
muscle cross-sectional area, fiber-type specific cross-sectional area, fiber-type
distribution and myonuclei abundance was quantified using MyoVision automated
analysis software [322].
Fecal DNA Extraction
Fecal samples were collected upon transferring co-housed mice to individual wheel
cages, prior to antibiotic administration and 48 hours prior to euthanasia at week 10.
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Fecal samples were collected by placing a single mouse in a clean, sterile plastic cage and
allowing the mouse to defecate at will. Fresh feces were placed in a sterile Eppendorf
tube and immediately placed in dry ice. Samples were then stored at -80°C until further
analysis. DNA was isolated using the PureLink™ Microbiome DNA Purification kit
(catalog no. A29790, ThermoFisher Scientific) according to the manufacturer’s
instructions. Briefly, samples were weighed and then subjected to mechanical (bead
beating), chemical and heat lysis, followed by washing and then final elution in 25 µl of
DNase-free water.
Metagenomic Sequencing
A subset of samples (n=6 for CU, PU, CT and PT (pre) and n=6 for CU, PT, n=5 for PU
and CT (post) were sent to CosmosID® (CosmosID Inc., Rockville, MD, United States)
for metagenomics sequencing as previously described [323]. Fecal DNA concentration
was quantified via fluorescent spectroscopy with a Qubit (ThermoFisher Scientific) and
DNA libraries were prepared using the ThermoFisher IonXpress Plus Fragment Library
Kit according to the manufacturer’s protocol. Library quantity was assessed with Qubit
and sequenced on a ThermoFisher Ion S5 XL sequencer. Single read sequences, without
adapters generated kmers between 150-300 base pairs. The short sequence reads were
first inputted into the reference genome curated by ComosID which generated variable
length k-mer fingerprints that were associated with distinct phylogeny of microbes. Next,
the short reads were aligned against a known set of variable length k-mers to yield a
precise taxonomic classification and relative abundance estimates for microbial next
generation sequencing datasets. False positives were excluded by using a filtering
threshold that was determined by analyzing large numbers of diverse metagenomes.
Sequences were referenced with CosmosID’s GenBook® database and analyzed using
the CosmosID cloud app (CosmosID Metagenomics Cloud, app.cosmosid.com,
CosmosID Inc., www.cosmosid.com). The curated database allows for high resolution of
millions of short reads corresponding to discrete microorganisms which are void of
contamination from the host. The Genbook® contains over 150,000 bacteria, viruses,
fungi and protist genomes, including both coding and non-coding sequences [324].
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Cytokine Assay
Serum cytokines (TNF-α, INF-γ, IL-6, IL-10 and IL-17a) were measured using Meso
Scale Discovery (MSD, Gaitherburg, MD), U-PLEX customized multiplex immunoassay
according to manufacturer’s directions. We have chosen to measure the serum
concentration of the cytokines because they are accepted markers of systemic
inflammation [325-328]. Following collection, blood was centrifuged at 1500 g for 15
minutes with the resulting serum centrifuged at 3000 g for 15 minutes. The cleared serum
was stored at -80°C until analysis. To measure serum cytokine levels, the stored serum
was thawed in duplicate, 25 µl aliquots added per well to MSD plate coated with capture
antibodies for TNF-α, INF-γ, IL-6, IL-10 and IL-17a.
Euthanasia
Twenty-four hours prior to euthanasia, all running wheels were locked for the PoWeR
trained mice. In addition, mice were fasted for 5-6 hours prior to euthanasia. Mice were
anesthetized by isoflurane (1-2%) inhalation, and once fully sedated, blood was collected
followed by excision of the heart (to ensure death) and then skeletal muscles.
Statistical Analysis
Data is presented as mean ± standard deviation (SD) with significance set at p-value <
0.050. A normality check was performed using a Shapiro-Wilk test. In the event the data
was not normally distributed, we performed a log transformation and reassessed for
normality to obtain a normal distribution. Weekly food and water consumption, body
weight and running volume was compared using a repeated measures 2-factor ANOVA
(Group X Time). Skeletal muscle fiber cross-sectional area, fiber-type specific crosssectional area, fiber-type distribution, myonuclei and Pax7+ abundance, end point body
weight, ceca weight, number of reads and number of bacterial species were analyzed by a
2-factor ANOVA (Antibiotic treatment X PoWeR training). In the case of significance,
post hoc analysis was performed using a Tukey’s-HSD to correct for multiple
comparisons. During the IHC analysis, one soleus in the CU group was damaged beyond
repair and was not included in any of the soleus comparisons. Outliers were detected first

34

by subtracting 1.5 x (IQR) from the first quartile and adding 1.5 x (IQR) to the third
quartile. We then cross checked using the Grubb’s test (Graph Pad).
Results
The study design is presented in Figure 2.1. During the four-week acclimation period
there were no reported complications with the mice. Upon completion of the acclimation
period, mice were randomly separated into singly housed running wheel cages with a prefecal (Pre) sample immediately collected. Once Pre-samples were collected, mice in the
antibiotic assigned groups began antibiotic treatment via drinking water for one week,
during which time running wheels remained locked. After the first week of antibiotic
treatment, running wheels were unlocked for those mice in the PoWeR groups. Upon
completion of PoWeR training, feces were collected 48 hours prior to euthanasia from all
mice to obtain a post-fecal (Post) sample. No complications were reported at any time
during the duration of this study including when the mice were singly housed in wheel
running cages, fecal collections or during the training period. One mouse in the CT group
died three days prior to the completion of the study with the cause of death unknown.
Dysbiosis of the Gut Microbiome by Antibiotic
Treatment
As shown in Figure 2.2A, there was no difference in the number of bacterial species
detected in the gut microbiome across all groups prior to antibiotic treatment. Antibiotic
treatment significantly (main effect of antibiotic treatment, (p < 0.0001) reduced the
number of bacterial species detected within the gut microbiome (Figure 2.2B);
furthermore, PoWeR training did not change the number of detected bacterial species
compared to their respective non-running control counterparts (Figure 2.2B) Importantly,
the loss of bacterial species with antibiotic treatment was not caused by a change in the
depth of reads as there was no difference in the number of reads pre- and post-treatment
between all groups (Figure 2.2C-D). For the reads at the post time point, one mouse in
the CU group was determined to be an outlier (Figure 2.2D). This mouse also had the
highest number of species at the post time point (Figure 2.2B), which could be
contributing to the higher number of reads. Antibiotic treatment caused a significantly
higher cecum weight (main effect of PoWeR training, p = 0.0087; main effect of
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antibiotic treatment, p <0.0001; interaction, p = 0.0352) (Figure 2.2E-F). An overview of
the microbiome at the genus taxonomic level revealed the antibiotic treatment was
effective in reducing the composition of the microbiota (Figure 2.3). Two of the five CT
samples had undetectable levels of bacteria and could not be included in the post lanes of
the heat map (Fig. 3). Together, these findings illustrate that antibiotic treatment
effectively induced dysbiosis of the gut microbiome which was not affected by PoWeR
training.
PoWeR Increased Food and Water Consumption
Time course analysis revealed higher food consumption, starting at weeks 1 and 2, and
water consumption, starting at weeks 3 and 5, and remained significantly higher in the
PoWeR groups compared to their respective non-running control counterparts for the
duration of the study (Figure 2.4A-B).
Body Weight
There was a significant main effect of time (p < 0.0001) and group (p = 0.0004) with a
significant interaction (p < 0.0001) for body weight throughout the study. The body
weight of the PT group was significantly higher than PU and CU groups from week 3
thru 10. In addition, the body weight of the CT group was significantly higher than the
PU for weeks 9 and 10 (Figure 2.4C). The higher final body weight of the antibiotic
treated groups was caused by enlargement of the cecum. When the cecum weight was
subtracted from the final body weight, there was no difference in body weight between
any groups (Figure 2.4D).
Running Volume
As shown in Fig. 5A-B, there was no difference in the weekly or total running volume
between the PoWeR groups despite a progressive increase in the amount of weight (2g to
6g) added to the running wheel over the course of the eight-week PoWeR training period.

Soleus
2.1.15.1 Muscle Wet Weight
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In response to PoWeR training, there was a significant main effect of PoWeR training (p
= 0.0002) and interaction (p= 0.0005) with a trend (p = 0.0540) for a significant effect of
antibiotic treatment for normalized (to body weight) soleus wet weight. Normalized
soleus wet weight was significantly larger in the PU group compared to CU (p < 0.0001),
CT (p < 0.0008) and PT (p < 0.0007). The PT showed no increase in normalized soleus
wet weight. These results were not affected by cecum weight as normalizing soleus
muscle wet weight to body weight without the cecum weight included still showed the
normalized soleus wet weight was significantly higher in the PU group compared to CU
(p < 0.0001), CT (p = 0.0008) and PT (p = 0.0007) groups (Figure 2.6B).
2.1.15.2 Fiber Cross-Sectional area (CSA)
In agreement with normalized soleus muscle weight, there was a significant main effect
of PoWeR training (p = 0.0001) on soleus mean fiber CSA (Figure 2.6C). Post hoc
analysis revealed the mean fiber CSA of the PU soleus was 29% larger than CU (p =
0.0012) and 31% larger compared to CT (p = 0.0007) while there was no difference in
mean fiber CSA between the CU, CT and PT groups. When comparing Type 1 fiber
CSA, there was a significant (p = 0.0302) main effect of PoWeR training on Type 1 fiber
CSA. Type 1 fiber CSA was trending towards significance (p = 0.0778) between PU and
CU groups and was significantly larger (p = 0.0464) between PU and CT groups (Figure
2.6D). Fiber-type specific CSA analysis showed the larger mean fiber CSA of the PU
soleus was primarily a result of larger Type 2a fiber CSA (main effect of antibiotic
treatment, p = 0.0330; main effect of PoWeR training, p < 0.0001; interaction, p =
0.0779) (Figure2.6D). The PU group had significantly larger Type 2a fiber CSA in
comparison to the fiber CSA of CU (p < 0.0001), CT (p < 0.0001) and PT (p = 0.0238)
groups. The PT group had significantly larger Type 2a fiber CSA compared to CT (p =
0.0463).

2.1.15.3 Myonuclei Abundance
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There was a significant (p = 0.0330) main effect of PoWeR training on myonuclei
abundance in the soleus muscle; however, post hoc analysis revealed no significant
difference between groups in response to PoWeR training.
2.1.15.4 Fiber-Type Composition
One mouse in the CT group was classified as an outlier (see Methods) for fiber-type
distribution and subsequently removed from all fiber-type distribution analyses. In
response to PoWeR training there was a main effect (p <0.0001) for Type 1 fiber
abundance. PU had 17% more Type 1 fibers compared to CU (p = 0.0058) and 20% more
compared to CT (p = 0.0026) while PT had 21% more Type 1 fibers compared to CU (p
= 0.0008) and 23% more compared to CT (p = 0.0004) (Figure 2.7B). Comparing the
abundance of Type 2a fibers, there was a significant main effect of PoWeR training (p <
0.0001). PU had 20% less Type 2a fibers compared to CU (p = 0.0220) and 15% less
compared to CT (p = 0.0116). PT had 25% less Type 2a fibers compared to CU (p =
0.0074) and 26% less compared to CT (p = 0.0039) (Figure 2.7B). In addition, there was
a significant (p <0.0001) main effect of PoWeR training on Type 2b/x fiber abundance.
PU had 88% less Type 2b+x fibers compared to CU (p = 0.0003) and 87% less compared
to CT (p = 0.0009). PT had 55% less Type 2b+x fibers than CU (p = 0.0312) and a trend
towards lower Type 2b/x fiber abundance compared to CT (p = 0.0613). There was no
difference in the abundance of fibers that co-expressed myosin heavy chain isoforms
Type 1+2a (Figure 2.7B).
Plantaris
2.1.16.1 Muscle Wet Weight
Analysis of normalized (to body weight) plantaris muscle wet weight with the cecum
included showed a significant (p = 0.0001) main effect of antibiotic treatment. Post hoc
analysis revealed that PU was significantly heavier compared to CT (p = 0.0108) and PT
(p = 0.0014) groups. Additionally, the CU group was significantly (p = 0.0467) heavier
compared to PT. In contrast to the soleus muscle, these differences did not persist when
plantaris muscle wet weight was normalized to body weight excluding the cecum (Figure
2.8 A-B).
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2.1.16.2 Fiber Cross-Sectional Area (CSA)
In response to PoWeR training, there was a significant (p = 0.0012) main effect of
training on mean fiber CSA (Fig. 8C). PU mean fiber CSA was 23% larger compared to
CT (p = 0.0109). There was a trend for significantly larger mean fiber CSA between PU
and CU (p = 0.0767) and between PT and CT groups (p = 0.0831) (Fig. 8C). In regards to
fiber-type specific CSA, there was a significant (p <0.0001) main effect of PoWeR
training on Type 2a fiber CSA. PU had 42% and 47% larger Type 2a fiber CSA
compared to CU (p < 0.0001) and CT (p < 0.0001), respectively (Figure 2.8D). PT had
27% and 31% larger Type 2a fiber CSA compared to CU (p = 0.0137) and CT (p =
0.0064), respectively (Figure 2.8D). There was a significant main effect of PoWeR
training (p = 0.0011) and main effect of antibiotic treatment (p = 0.0282) for Type 2b/x
fiber CSA (Figure 2.8D). Type 2b/x fibers of PU were 24% larger compared to CU (p =
0.0257) and 37% larger compared to CT (p = 0.0013). Type 2b/x fiber CSA was not
different when comparing PT to CU (p = 0.8000) and CT (p = 0.1827) groups (Figure
2.8D).
2.1.16.3 Myonuclei Abundance
There was a significant (p = 0.0120) main effect of PoWeR training for myonuclei
abundance. Myonuclei abundance of PU was 65% higher compared to CU (p = 0.0136)
and 51% compared to CT (p = 0.0494) (Figure 2.8E). There was no difference in
myonuclei abundance when comparing PT and CT groups (p = 0.9443).
2.1.16.4 Satellite Cell Abundance
Satellite cell abundance was determined using Pax7 immunohistochemistry. There was a
significant main effect of PoWeR training (p = 0.0467) and interaction (p = 0.0401) for
the abundance of Pax7+ nuclei/100 fibers. Post hoc analysis revealed PU had 50% more
Pax7+ nuclei compared to the CU (p = 0.0236). There was no difference (p = 0.2782) in
satellite cell abundance between the CU and CT groups. Finally, there was no difference
(p = 0.6546) when comparing the PU and PT groups in satellite cell abundance (Figure
2.8G).
2.1.16.5 Fiber-Type Composition
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There was a significant (p < 0.0001) main effect of PoWeR training on the percentage of
Type 2a fibers (Figure 2.9B). PU had 89% more Type 2a fibers compared to CU (p <
0.0001), 94% more compared to CT (p < 0.0001) and 24% more compared to PT (p =
0.0467) (Figure 2.9B). PT had 52% more Type 2a fiber compared to CU (p = 0.0031) and
57% compared to the CT (p = 0.0025) (Figure 2.9B). We also observed a significant main
effect of PoWeR training (p < 0.0001) and interaction (p = 0.0127) for Type 2b/x fiber
abundance (Fig. 9C). PU had 66% fewer Type 2b/x fibers compared to CU (p < 0.0001),
60% fewer than CT (p < 0.0001) and 24% less than PT (p = 0.0186) (Figure 2.9B). In
addition, PT had 34% fewer Type 2b/x fibers compared to CU (p = 0.0004) and 29% less
compared to CT (p = 0.0040) (Figure 2.9C). As shown in Figure 2.9B, there was no
difference in the abundance of Type 1 and hybrid fibers that co-expressed myosin heavy
chain isoforms (Type 2a+Type2b/x) across all groups.
Serum Cytokine Levels
IL-6 concentrations of one mouse from the PU group was found to be an outlier.
Additionally, IL-17a from another mouse in the PU group was also determined to be an
outlier. We moved these values from the specific cytokine analysis. There was no change
in the serum concentration of IL-10, IFNγ, TNFα, or IL-17a in response to antibiotic
treatment and/or PoWeR training (Figure 2.10). When looking at IL-6, there was a
significant (p = 0.0236) main effect of PoWeR training. Post hoc analysis revealed a
trend for IL-6 levels to be elevated when comparing PU to CU (p = 0.0590).
Discussion
The major finding of the study is that antibiotic-induced dysbiosis of the gut microbiome
impaired the ability of skeletal muscle to adapt to exercise training. Despite a similar
training stimulus between untreated and antibiotic-treated groups, dysbiosis resulted in
blunted hypertrophy in both the soleus and plantaris muscles following PoWeR training.
In the soleus muscle of mice with a disrupted gut microbiome, skeletal muscle
hypertrophy of Type 1 fibers was blunted and the trend for larger Type 2a fibers observed
in untreated mice did not occur. Similarly, in the plantaris muscle, dysbiosis of the
microbiome prevented the greater Type 2b/x fiber CSA following PoWeR training
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observed in mice with an intact gut microbiome. In untreated mice, the greater abundance
of both satellite cells and myonuclei in the plantaris muscle in response to PoWeR
training was absent in dysbiotic mice, which likely contributed to their blunted
hypertrophic response. We did not find an increase in myonuclei accretion in the soleus
muscle and therefore decided to not quantify satellite cell abundance in the soleus
muscle. Lastly, the major fiber-type shifts induced by PoWeR training was unaffected by
antibiotic-induced dysbiosis of the gut microbiome in the soleus muscle. However, Type
2a fiber abundance nearly doubled in the plantaris muscle which was significantly less in
mice with a suppressed microbiome. These findings agree with previous studies showing
the gut microbiome influences skeletal muscle mass and fiber-type composition and
provide the first detailed evidence that an intact gut microbiome is necessary for skeletal
muscle to fully adapt to exercise training [197, 199]
An important finding from our study was that antibiotic-induced dysbiosis of the
microbiome did not affect running activity which was critical to ensure a similar training
stimulus between the two PoWeR groups. In fact, it might be argued that the training
stimulus was greater in the antibiotic treated mice given their heavier body weight caused
by an enlarged cecum. In contrast, previous studies found that both antibiotic treated
mice and GF mice have reduced exercise performance suggesting a role for the gut
microbiome in exercise activity [202, 250, 317]. The discrepancy in exercise activity
between these studies and our own could be explained by the lower dose of antibiotics
used in the current study or that the mice in this study were given free access to a running
wheel while the other studies used time to exhaustion with untrained mice. The antibiotic
treatment itself may have negatively impacted exercise time to exhaustion as has been
reported in athletes [329]. Alternatively, it could be plausible that an intact gut
microbiome is needed for maximal exercise capacity as compared to sub-maximal wheel
running exercise activity.
The use of antibiotics in lieu of GF mice is a common method to assess the role of
the gut microbiome in health and disease [330]. GF mice are costly, labor intensive and,
as shown previously, display muscle atrophy associated with higher expression of
atrogenes [199], which creates an issue when trying to investigate the role of the gut
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microbiome in skeletal muscle adaptation to exercise. We decided to use antibiotics to
suppress the microbiome in order to allow us to use mice in which skeletal muscles, as
well as other systems like the immune system, had undergone normal development and
maturation with an intact gut microbiome [331, 332]. The lack of an established
antibiotic dosing regimen that effectively depletes the gut microbiome with minimal side
effects, however, leaves open the possibility that the antibiotics themselves may be
directly interfering with cellular and/or molecular mechanisms involved in skeletal
muscle adaptation to exercise.
Dysbiosis of the gut microbiome by antibiotics is known to alter immune cell
activation which causes a thinning of the mucosal layer with a concomitant increase in
intestinal epithelial cell permeability [333-335]. The increase in intestinal permeability
with dysbiosis is known to induce low-level systemic inflammation which might induce a
state of anabolic resistance leading to the impaired hypertrophic growth observed in
antibiotic-treated PoWeR-trained mice. While this possible scenario awaits further
investigation, we found no difference in the serum levels of inflammatory cytokines
across all groups indicating the absence of low-level systemic inflammation induced by
antibiotic treatment. However, these measurements were taken upon completion of
PoWeR training allowing for the possibility that systemic inflammation was different at
some earlier time point of the study. This concern is offset by the finding that nonrunning control muscle weights and running activity were not different between antibiotic
treated mice nor mice with an intact gut microbiome; thus, indicating antibiotic treatment
had minimal effect on skeletal muscle maintenance and function.
What evidence is there to suggest antibiotics might interfere with skeletal muscle
adaptation to exercise? A study reported high doses of the antibiotic metronidazole can
cause skeletal muscle atrophy; however, this study used a dose 10-fold greater than the
dose administered in the current study [336]. Other studies have shown that high doses of
aminoglycosides such as gentamycin, neomycin and streptomycin, can affect calcium
signaling but these studies used a dose 100-fold greater than the dose used in the current
study. Hayo and colleagues utilized eccentric exercise to induce muscle damage in rats
who were administered streptomycin, which can reduce intracellular calcium
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concentration by blocking stretch activated channels. Although these authors found that
streptomycin reduced muscle membrane permeability, it did not affect the amount of
myofiber swelling using a dose 80-fold greater than the dose used in the current study
[337]. Most recently, Qiu and colleagues reported antibiotic-induced dysbiosis caused
muscle atrophy which was shown to be mediated by a suppression of bile acid signaling
to FGF15; however, as with the aforementioned studies, these authors used antibiotic
doses 100 time greater than those used in the currents study [338]. Finally, intraperitoneal
injection of the antibiotic imipenem for five consecutive days did not affect muscle
specific force [339]. Collectively, these studies demonstrate that antibiotic doses 10-100
times greater than the dose we used can negatively affect muscle size but not muscle
function. Given that we observed no difference in muscle phenotype (weight and fiber
size and composition) between non-running control groups as well as wheel running
activity, we think the relatively low dose of antibiotics administered was able to
effectively induces dysbiosis while minimizing any side effects that might have interfered
with skeletal muscle adaptation to exercise.
The blunted hypertrophic growth response observed in both slow- and fast-twitch
myofibers could be due to a common gut-derived microbial metabolite(s) which is
necessary for maximal muscle growth. In support of such a mechanism, Chen and
colleagues discovered that B. theta C34 bacteria produce L-phenylalanine, an agonist of
G-coupled protein receptor 56 (GPCR-56) which was previously shown to be sufficient
for skeletal muscle hypertrophic growth as well as required for mechanical overloadinduced hypertrophy [340, 341]. Similarly, in a series of studies led by Sato and Sasaki,
activation of the G-couple protein bile acid receptor TRG5 was shown to promote
skeletal muscle hypertrophy and improve glucose metabolism [263, 265]. In particular,
these authors reported administration of the gut microbial-derived bile acid metabolite,
taurolithocholic acid, induced expression of pro-hypertrophy genes Nr4a1 and Pgc-1α4
in transgenic mice that overexpressed TGR5 [263]. Future studies will need to
mechanistically determine if gut microbial-derived metabolites play a role in skeletal
muscle adaptation to exercise.
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Antibiotic dysbiosis of the gut microbiome did not impair the exercise-induced
fiber-type shifts in the soleus muscle but did in the plantaris muscle. In the soleus, the
loss of Type 2a fibers was similar between the PoWeR-trained groups whereas in the
plantaris, the higher abundance of Type 2a fibers was significantly less in mice with a
suppressed microbiome. This finding suggests there is some microbial-derived factor(s)
that may be necessary to promote the transition to a more oxidative phenotype. In support
of this idea, Yan and colleagues demonstrated that the microbiome from two different
types of pigs (the obese Rongchang and the lean Yorkshire) could give rise to their
distinct muscle fiber-type composition when transferred to GF mice [197]. Based on
succinate dehydrogenase staining and gene expression, GF mice were found to have a
loss of oxidative capacity across different hind limb muscles that was partially restored
following microbial transfer [199]. Collectively, these findings along with the results
from the current study support the idea that the gut microbiome facilitate the transition to
a more oxidative phenotype in skeletal muscle.
Satellite cell and myonuclei abundance of the plantaris muscle were higher in
response to PoWeR training in mice with an intact gut microbiome. The effect of
dysbiosis on satellite cells was more ambiguous because some mice in both groups,
sedentary and runners, showed higher abundance of satellite cells while other mice
appeared to be unaffected by dysbiosis. This variability led to there being no difference in
satellite cell abundance between the two PoWeR trained groups. This variable response
to dysbiosis may reflect the inherent molecular heterogeneity of satellite cells as revealed
by single-cell RNA-sequencing to changes in microbial-derived metabolites, though
confirmation of such a mechanism awaits further study [342].
Limitations
The current study has some important limitations that need to be acknowledged. For this
initial study, we chose to use C57BL/6J female mice because they are known to be better
runners than their male counterparts [343] and we were concerned the disruption of the
gut microbiome might negatively impact exercise activity as previously reported [202,
317]. Since the running activity was the same between the antibiotic-treated and
untreated groups, thus having an equivalent training stimulus, we were able to draw
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stronger conclusions about the influence of the gut microbiome on skeletal muscle
adaptation to exercise. Given the reported sexes differences in host-gut microbiome
interactions, it will be important for a future study to determine is dysbiosis in males also
blunts muscle adaptation to exercise training as observed in females [344, 345]. Beyond
wheel running activity, we did not perform any muscle function analyses to determine if
the observed phenotypic differences between the PoWeR-trained groups was associated
with any change in functional characteristics of the muscle. Thus, future work will need
to determine if the changes in fiber size and composition induced by dysbiosis have an
impact on maximum and specific force and fatiguability of the muscle. Finally, there is a
wide variety of rodent diets used in pre-clinical research which have been reported to
significantly alter the composition of the gut microbiome and the production of shortchained fatty acids [346]. Importantly, all mice in the current study consumed exactly the
same high protein diet for the duration of the study to ensure adequate protein intake to
support skeletal muscle growth in response to PoWeR training.
Conclusions
The findings of this study demonstrate that an intact gut microbiome is required for
skeletal muscle to fully adapt to exercise training. Additionally, the findings from this
study add to the growing body of evidence supporting a gut microbiome-skeletal muscle
axis [195, 198, 199, 219]. Future studies will seek to identify the bacterial species and
associated metabolites that play a critical role in facilitating skeletal muscle hypertrophy
and the fiber-type shift that occur in response to exercise with the expectation they will
be unique for each of these processes.
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Figure 2.1 Study Design.
Animals were cohoused in groups of four-five for four weeks in order to allow for
acclimation to the animal facility at the University of Kentucky. Upon the completion of
the acclimation period, mice were randomly split into four different groups and singly
housed in running wheel cages. Immediately after randomization into study groups, the
first fecal samples were collected (pre), prior to antibiotic administration. During the first
week of being singly housed, all wheels were locked, and the antibiotic treatment began.
One week after, the wheels were unlocked for those mice in the PoWeR groups, initiating
the acclimation week. After the first week of acclimation with an unload wheel, 2g was
placed on one side of the running wheel to add resistance Each week thereafter, an
additional 1g was added to the wheel until the load reached a total of 6g for the final three
weeks of training. A final fecal sample was collected roughly 48 hours prior to
euthanasia. After completion of eight weeks of PoWeR training, mice were euthanized,
and tissues were collected for analysis. Image created with BioRender.
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Figure 2.2 Gut Microbial Dysbiosis with Antibiotics
Gut Microbial Dysbiosis with Antibiotics: Antibiotic induced dysbiosis of the gut
microbiome. (A) Number of individual bacterial species before (pre) and (B) after (post)
antibiotic treatment and PoWeR training n=5-6 per group. (C) Number of reads during
sequencing corresponding to the pre and (D) post time points, n=5-6 per group. (E)
Representative image of a cecum harvested from an untreated and treated mouse (F)
Differences in ceca weight between the groups, n= 9 -11 per group. Bars are mean values,
dots represent individual values. Errors bars = standard deviation. * = p < 0.05
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Figure 2.3 PoWeR and Antibiotic Induced Changes to the Gut Microbiome
Heat map indicating the microbial composition at the genus levels between groups at the
pre and post time points. n= 3-6 per group.
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Figure 2.4 Food & Water Consumption, and Body Weights
Food consumption, water intake and body weight changes during PoWeR training. (A)
Weekly food consumption during training, (B) Weekly water intake during study, (C)
Weekly body weight during study, (D) Body weight at the point of sacrifice with the
cecum removed. Bars are means and dots represent individual values. Points on A, B and
C represent group averages for that week, Errors bars = standard deviation. n=9 -11 per
group.* significantly different (p < 0.05) PT vs CT for food and water intake data. †
Significantly (p < 0.05) different PU vs CU for food and water intake. * Significantly (p
< 0.01) different PT vs CU & PU. † = Significantly (p < 0.05) different CT vs PU for
body weights.
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Figure 2.5 Antibiotic Induced Dysbiosis of the Gut Microbiome Does Not Impair
Exercise Activity.
Running volume during PoWeR training. (A) weekly running volume (km/day) of the
PoWeR untreated and treated groups, (B) Mean total distance run during PoWeR training
between PoWeR untreated and treated groups n=11 per group. Bars represent means, dots
represent individual mice, filled circles on A represent group averages for the
corresponding week and error bars = standard deviation.
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Figure 2.6 Antibiotic Induced Dysbiosis of the Gut Microbiome Results in a
Blunted Hypertrophic Response in the Soleus.
Analysis of the soleus muscle after PoWeR training with or without dysbiosis. (A)
Normalized soleus wet weight to body weight including the cecum, (B) Normalized
soleus wet weight to body weight excluding the cecum, (C) Soleus mean cross-sectional
area (7µm sections), (D) Type 1 and type 2a skeletal muscle cross sectional area fiber
cross-sectional area (7µm sections). n=8 -11 per group. Bars represent means, dots
represent individual mice, error bars = standard deviation. *= p <0.05.
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Figure 2.7Antibiotic Induced Dysbiosis of the Gut Microbiome Does Not Impair
Skeletal Muscle Fiber-Type Shift in the Soleus
Analysis of the fiber-type distribution in the soleus muscle after PoWeR training. (A)
Representative image of soleus cross section, (B) Fiber type distribution for type 1, type
2a, type 2b/x and co-expression (hybrid) skeletal muscle fibers. n=7 -11 per group. Bars
represent means, dots represent individual mice, error bars = standard deviation. *= p
<0.05.
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Figure 2.8 Antibiotic Induced Dysbiosis of the Gut Miccrobiome Results in
Blunted Hypertrophy, Myonuclei Accretion and Altered Satellite Cell Abundance in the
Plantaris
Analysis of the plantaris muscle after PoWeR training. (A) Normalized plantaris wet
weight to body weight including the cecum, (B) Normalized plantaris wet weight to body
weight excluding the cecum, (C) Plantaris mean fiber cross-sectional area (7µm sections),
(D) Type 2a and type 2b/x skeletal muscle cross sectional area fiber cross-sectional area
(7µm sections), (E) Number of myonuclei per fiber, (F) Representative image of Pax 7+
myonuclei (G) Satellite cells per 100 muscle fibers. n=9 -11 per group. Bars represent
means, dots represent individual mice, error bars = standard deviation. * = p < 0.05.
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Figure 2.9 Antibiotic Induced Dysbiosis of the Gut Microbiome Results in a
Blunted Fiber-Type Shift in the Plantaris
Analysis of the fiber-type distribution in the plantaris muscle after PoWeR training. (A)
Representative image of plantaris cross section, (B) Fiber type distribution for type 1,
type 2a, type 2b/x and co-expression (hybrid) skeletal muscle fibers. n=9 -11 per group.
Bars represent means, dots represent individual mice, error bars = standard deviation. *=
p <0.05.
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IL-6

Figure 2.10 10 Weeks of Antibiotics Administration and PoWeR Training did Not
Augment Inflammation
Serum concentrations of inflammatory markers taken after nine weeks of training and
antibiotic administration. n = 9 -11 per group. Bars represent means, dots represent
individual mice, error bars = standard deviation. Il-6, IL-10 and TNF-α were log
transformed.
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CHAPTER 3. THE

GUT MICROBIOME FROM AN EXERCISE TRAINED HOST AMELIORATES
SKELETAL MUSCLE ATROPHY.

Introduction
The loss of skeletal muscle mass occurs rapidly, with decreases in muscle cross sectional
area (CSA) observed within the first week of week of hospitalization due to critical
illnesses [347], immobilization [348] or space flight [145]. The loss in muscle mass and
strength is associated with all-cause mortality, increased risk for hospitalization and decline
in quality of life. Furthermore, after the age of 75, muscle mass begins to decrease roughly
1% per year with concomitant decreases in strength of about 3% per year [349]. While
exercise has been demonstrated to promote many positive adaptions in muscle health, the
implementation of physical activity may not be realistic in many situations such as
immobilization and disease. Pharmacological interventions can be utilized to attenuate the
loss of muscle mass in disease states [350], yet they are not without contraindications. For
example, pharmacologic interventions to treat muscle loss was shown to induce liver
damage in one out of 21 patients undergoing treatment with oxymetholone [18]. In a group
of 106 men receiving testosterone supplementations to increase muscle mass, 23
experienced cardiovascular related events [19]. Nutrition represents yet another
intervention to combat muscle wasting; however, there is a currently lack of nutritional
supplementation for those populations who are most at risk for severe muscle loss [351].
Other reports have indicated that in the absence of exercise, nutritional interventions alone
are not able to effectively restore muscle mass or strength in older adults [16, 17]
Therefore, additional strategies to treat or prevent the decline in muscle mass and function
are needed.
Recently the gut microbiome has been shown to influence skeletal muscle
hypertrophy, fiber-type shift, myonuclear accretion, grip strength and exercise capacity
[199, 205, 352], suggesting the gut microbiome can regulate skeletal muscle phenotype
and function. Exercise has also been shown to modulate both the composition and function
of the microbiome [180, 302]. How exercise can modulate the composition and function
of the microbiome remains unknown. There is some evidence that exercise is able increase
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the production of microbially-derived short chain fatty acid such as acetate, butyrate and
propionate [353]. Interestingly, butyrate was recently shown to prevent skeletal muscle
atrophy and decrease the expression of atrogin-1 and MuRF1 in skeletal muscles of mice
[199, 200].
Studies in mice have shown that exercise training results in compositional changes
to the microbiome that are associated with a protective effect against sepsis [354] and
myocardial infraction [355]. While the findings from these studies are very promising, they
failed to determine if the benefits observed were solely derived from the exercise alone or
the effects of the exercise on the gut microbiome. In a pivotal study which transplanted the
microbiome from exercise-trained mice into exercise naïve recipient mice, Allen and coworkers demonstrated the microbiome of an exercise-trained host was shown to be
protective in a mouse model of colitis [305]. These results were the first evidence of the
therapeutic potential of the microbiome from exercise-trained host. The aim of this study
was to determine if the microbiome of an exercise-trained host could mitigate skeletal
muscle atrophy induced by 10 days of limb immobilization. We hypothesized that mice
receiving the gut microbiome of an exercise-trained host would experience less atrophy
compared to mice receiving the gut microbiome from sedentary control animals.
Methods
Mice
Recipient Mice: Twelve-week-old female C57BL/6J mice were purchased from The
Jackson Laboratory and then allowed to acclimate for four weeks after arrival to the animal
facility. Montonye and co-workers found that during the first week of acclimation in a new
facility, there was significant shifts in both the composition and function of mice
microbiomes [315]. It was shown that the microbiome stabilized between seven and 28 day
after arrival to a new facility [315]. Therefore, to ensure a stable and acclimatized
microbiome in the recipient mice, the experimental procedures began four weeks after
arrival. During the first week of acclimation, mice were randomly split into two groups
(n=9 mice per group) and designated as Rex (recipient of exercised host) or Rsed (recipient
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of sedentary host) and housed in groups of three referred to as Rex-1, -2 or -3 and Rsed-1,
-2 and -3.
Donor Mice: Cecal contents were harvested from donor mice who had previously
underwent 8-weeks of processive weighted wheel running (PoWeR) (Dex, donor
exercised) or remained as sedentary control (Dsed, donor sedentary) [352]. We used the
same design for Dex and Dsed groups as used for the recipient groups by making a
combined cecal slurry for cecal microbial transplant (CMT) from three Dex or Dsed mice
which produced Dex-1, -2 and -3 and Dsed-1, -2 and -3 groups (Figure 3.1 B). Body weight
and food consumption was recorded each week for the duration of the study.
Mice were monitored daily, and cages were changed once per week. To minimize
the potential for a drift in the microbial composition between individual cages of the same
group, old bedding from each group was pooled, mixed with clean bedding, and then
distributed to clean cages of the group.

PEG Bowel Clearing and Cecal Microbial Transfer
After the four-week acclimation period Rex and Rsed mice were gavaged with
polyethylene glycol (PEG) (SLBZ3934, Sigma-Aldrich, St. Louis MO) to clear the gastrointestinal track, as previously described [356, 357]. Briefly, PEG was dissolved in
autoclaved miliQ water at a concentration of 425g/L. Mice were sedated with isoflourane
and gavaged (FTP-20-30-50 plastic feeding tubes 20gsx30mm, Instech Laboratories,
Plymouth Meeting PA) with a 200µl bolus of PEG. This was repeated every 20 minutes,
so that each mouse received a total of 800µl of PEG in 60 minutes. After the final dose of
PEG, mice were placed in a clean sterile cage, void of bedding and food for six hours prior
to the first CMT.
Cecal Microbial Slurry: Cecal contents from nine Dex and nine Dsed were used to make
the cecal slurry. The cecal contents of three mice were pooled to generate three sub-groups
(Figure 3.1 B). This was implemented to create biological triplicates, to decrease the interindividual variability that exists in microbiome transfer studies [358]. The Dex groups were
matched to control for running volume such that each Dex group had similar total running
volume. A small aliquot of the cecal slurry from each Dex and Dsed sub-group was set
aside for metagenomic sequencing. The cecal contents were mixed, placed in a sterile 15
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ml tube with and 5 ml of sterile PBS added. The cecal concentration was approximately
150 mg/ml. The slurry was then vortex vigorously and centrifuge at 500 rpms for eight
minutes to pellet non-soluble microbial cell fraction. Sterile conditions were used to
prepare each slurry but under aerobic conditions. The resultant slurry was then distributed
into 2ml aliquots and immediately stored at -80 °C.
Cecal Microbial Transfer:
Six hours after the final bolus of PEG, mice were administered their first CMT. Mice were
sedated with isoflurane and gavage with a 200 µl bolus of cecal slurry. Twenty-four and
48 hours after the first CMT, mice received their second and third bolus. The mice then
received a CMT once per week for the next four weeks, prior to the immobilization. Mice
received a total of seven CMT throughout the study.

Limb Immobilization
The unilateral limb immobilization procedure was performed as previously described
with minor modifications [144]. Briefly, a capless 0.6 ml centrifuge tube was cut 1 cm
down from the opening and attached to small paper clip (ACC72320, No. 3, ACCO
Brands, Inc., Lincolnshire, IL) with the adhesive side of a 0.5 cm x 3 cm Velco strip
(Velcro 90198, Velcro USA, Inc., Manchester, NH). The mice were sedated with
isoflurane and the right hind leg was carefully placed into the tube in a slightly
plantarflexed position. The foot was secured to the paper clip by using an additional 0.5
cm x 3 cm Velcro strip. Two strips of tape were then applied to the cast in order to
provide reinforcement. Each day of the 10-day immobilization period, mice were
checked to determine if the cast had been removed. If a cast was removed the mouse was
sedated with isoflurane and the cast re-applied as described above. One mouse in Rex-1
group removed the cast on the final day of immobilization.
Immunohistochemistry
Immunohistochemistry (IHC) analysis was performed as previously described by us [56,
314] on the soleus and plantaris muscles to determine skeletal muscle fiber cross-sectional
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area, fiber-type composition, and myonuclei abundance. Excised soleus muscles were
immediately weighed, with one limb snap-frozen in O.C.T using liquid nitrogen-cooled
isopentane with muscles from the other limb snap-frozen in liquid nitrogen and then stored
in -80°C for biochemical and molecular analyses. Muscle samples were mounted and cut
into 7µm sections. Muscle sections were air-dried overnight at room temperature. After
drying, the sections were incubated in a cocktail of iso-type specific anti-mouse primary
antibodies against myosin heavy chain MyHC-1 (IgG2B, BA.D5), MyHC-2a (IgG1,
SC.71) and MyHC-2b (IgM, BF.F3) from Developmental Studies Hybridoma Bank
(DSHB Iowa City, IA) in addition Rabbit anti-Laminin (1:100, Sigma #L9393( was used
to delineate the fiber border). Type-2x fibers were not stained and counted based on the
lack of staining. Primary antibodies were diluted 1:100 in PBS with slides incubated for
in 4 °C overnight. Sections were subsequently washed three times with PBS and incubated
with secondary antibodies (1:250, goat anti-mouse IgG2b Alexa Flour 647, #A21242;
1:250 IgG1 Alexa Flour 488, #A21121; 1:250, IgM Alexa Flour 555, #A21426) from
Invitrogen (Carlsbad, CA, USA). Goat anti-rabbit IgG, AMCA was used for the secondary
for laminin (Vector Laboratories, CL-1000). Slides were incubated with secondary
antibodies for 90 minutes at room temperature. Sections were then washed three times in
PBS and mounted using PBS:glycerol solution at a 1:1 ratio.
Image Capture and Analysis
IHC sections were captured at 20X magnification using an upright fluorescence
microscope (AxioImager M1, Zeiss, Oberochen, Germany). Quantification of skeletal
muscle cross-sectional area, fiber-type specific cross-sectional area and fiber-type
distribution was quantified using MyoVision automated analysis software [322].
Microbial DNA Extraction and Sequencing
Microbial DNA was extracted from the cecal contents as previously described [352].
Briefly, upon euthanasia, the cecum was excised and the contents were carefully removed
with a small spatula. The contents were placed in a 1.5 ml centrifuge tube and immediately
flash frozen in liquid nitrogen. DNA was isolated from cecal content using the PureLink
Microbiome DNA purification kit (ThermoFisher Scientific, Waltham, MA), Thermofisher
Scientific) according to the manufacturer’s instructions.
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Metagenomic Sequencing
Metagenomic sequencing was performed on extracted microbial DNA using HiSeq X Ten
(Illumina) with a read length of 150 bp paired end reads and a sequencing depth of three
Gigabase per sample. Taxonomic classification was performed with MetaPhlan3 [359] .
Briefly, samples were processed for quality control using KneadData which trims low
quality reads, and removes host-derived sequences. Processed sequences were then sent
through the ChocoPhlan 3 pipeline to align and organize microbial genomes to the
reference database (Uniprot [360] and NCBI Resource Coordinators and Coordinators
[361]). Raw reads were mapped to the database using bowtie2. To obtain the functional
profiling of the microbial communities, sequences processed by MetaPhlan3 were run
through HUMAnN3 (the HMP Unified Metabolic Analysis Network)[359]. The functional
profile was performed using pangenomes annotated with Uniref90 IDs that were generated
from MetaPhlan3.

For compositional analysis, ATIMA (Agile Toolkit for Incisive

Microbial Analysis, Alkek Center for Metagenomic and Microbiome Research, Baylor
College of Medicine) software was used to determine α- and β-diversity and taxa
abundance metrics. Rarefaction depth was set to 457,953 reads and resulted in 23/24
samples retained. This depth was chosen in order to include as many samples for analysis
and avoid having skewed groups to compare. One sample in the Rsed group was excluded
due to having extremely low reads (444). At the chosen rarefication depth 10,532,919 reads
were retained which was 15.5% of total reads. Mean abundance was set to ≥ 0.05%.
MaAsLin2 (Multivariable Association Discovery in Population-scale Meta-Omics Studies)
[362] was used to compare functional and metabolite data. To identify potential
metabolites, outputs from HUMANn2 analyses were processed through MelonnPan
(Model-based Genomically Informed High-dimensional predictor of Microbial
Community Metabolic Profiles) [363].
Statistics
To test for differences between body weight and food consumption during the experimental
period, a repeated measures ANOVA was used. When comparing the non-immobilized and
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immobilized leg of Rsed and Rex, a matching (non-casted to casted leg) 2-way ANOVA
was used. If a main effect or interaction was found, a SIDAK multiple comparison test was
used. When comparing the % difference in atrophy between the Rsed and Rex, paired,
Welches t-test was used. A difference in bacterial specie abundance between groups was
analyzed with a Mann-Whitney U test with an alpha set to p ≤ 0.05 and an FDR set to p <
0.10.
Results
No Adverse Effects of CMT or Immobilization on
Body Weight and Food Consumption
During the study, the Rsed and Rex were significantly heavier in weeks 5,6,7 and 8 (Rex
only) compared to weeks 1 and 2 (Figure 3.1 D). However, there were no differences in
body weight between Rsed and Rex at any time during the study. In addition, there was no
differences in food consumption (Figure 3.1 E). The running volume of the Dex sub-groups
were similar; Dex-1 = 796.6 ± 81.33 km; Dex-2 = 837.2 ± 78.05 km; Dex-3 = 813 ± 193.4
km (Figure 3.1 F). During the 10-day immobilization period, one mouse from Rex-1
removed the cast on the final day of immobilization.
The Gut Microbiome from an Exercise Trained Host
Blunts Skeletal Muscle Atrophy in the Soleus
Immobilization of the hind limb resulted in significant atrophy in the soleus of both the
Rsed and Rex groups, when looking at both normalized muscle wet (Figure 3.2 A), mean
fiber cross-sectional area (CSA) and fiber-type specific CSA. (Figure 3.2 B-E). There was
no difference in normalized muscle weight or mean fiber CSA when comparing the
immobilized leg of Rsed to Rex. However, when comparing the percent change in mean
fiber CSA between the non-immobilized and immobilized leg of each group, there was a
significant difference (p = 0.006) in the magnitude of reduction -42.71 ± 13.9 and -27.72
± 4.46% for Rsed and Rex, respectively (Figure 3.2 F). Similarly, the percent decrease in
Type-1 fiber CSA was significantly different (p = 0039) between Rsed and Rex (-38.47 ±
10.01% vs -22.08 ± 18.53%, respectively) (Figure 3.2 G). There was a trend (p = 0.06) for
the percent decrease in Type-2a fiber CSA for Rsed compared to Rex (-42.62 ± 10.11% vs
-33.82 ± 13.0%, respectively) (Figure 3.2 H).
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The Gut Microbiome from an Exercise Trained Host
Preserves Type2a fibers in the Soleus
The fiber-type composition of the soleus showed no change in the abundance of Type-1
fibers when comparing the non-immobilized to the immobilized leg for both Rsed and Rex
groups (Figure 3.2 I). The Rsed group had significantly less (p = 0.047) Type-2a fibers in
the immobilized leg compared to the non-immobilized leg; this difference was not
observed in the Rex group (Figure 3.2 J). When looking at the abundance of Type-2b+x
fibers, there was a significant increase in the immobilized leg compared to the nonimmobilized leg for both Rsed and Rex groups (p = 0.016 and p = 0.009, respectively)
(Figure 3.2 K).
Changes in Microbial Composition and Function after
CMT
To broadly characterize the microbial composite resulting from CMT, we determine - and
-diversity. Following CMT, there were no differences in α-diversity between Rsed and
Rex as assessed by the Shannon and Simpson Index (Figure 3.3 A). However, the Rex had
significantly more observed OTUs compared to the Rsed (adj. p = 0.0059), suggesting
samples in Rex had more low abundant taxa compared to Rsed (Figure 3.3 A). This is also
demonstrated by the Choa1 measure, which indicated some samples in Rex contained more
rare species (Figure 3.3A) suggesting Rex had greater species richness compared to Rsed.
A comparison of Dsed and Dex microbial composition showed no differences in αdiversity between the donor groups (Figure 3.3 B).
The β-diversity analysis demonstrated that there was a clear difference between the
Rsed & Rex as measured by weighted Bray-Curtis (p = 0.001) (Figure 3.4 A); however,
there was no difference in -diversity of Dsed and Dex groups (Figure 3.4 B). Principle
component analysis showed no difference between Dsed and Rsed groups (Figure 3.5 A)
but did reveal a significant (p = 0.005) differences in β-diversity between the Dex and Rex
groups (Figure 3.5 B). These results indicate there was higher dissimilarity between the
Dex and Rex groups. If the comparison between donor and recipient groups was restricted
to the top 10 most abundant species, which accounted for ~80% of the total identified
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microbes, there was no differences between the donors and their respective recipients
(Figure 3.5 C-D).
I next sought to identify species that were successfully transferred from Dex to Rex
that were not observed in Dsed or Rsed. Initial comparisons were performed at the genus
levels (Figure 3.6 A) and species levels (Figure 3.6B). Composition differences at the
species level revealed Muribaculaceae Bacterium DSM 103720 to be only present in Dex
and Rex groups suggesting it was an exercise-influenced microbe that engrafted from
donor to recipient (Figure 3.7 B). In addition to Muribaculaceae Bacterium DSM 103720
there were seven other species identified that were significantly (adj. p < 0.05) different
between Rsed and Rex (Figure 3.7 B & Table 3.1). Interestingly, Akkermanisa
muciniphilia was present in both Dsed and Dex, however it was significantly (adj. p =
0.00274) more abundant in Rex compared to Rsed (Figure 3.7 B). Although not significant,
a similar trend was also seen for the species Bacteroides thetaiotamicron. Further analysis
found

Faecalibaculum_rodentium,

Turicimonas_muris,

Parasutterella_excrementihominis,

Ileibacterium_valens,

unclassified

Proteobacteria_bacterium_CAG_139, Clostrium_cocleatum and Olsenella_scatoligenes
species were all significantly higher in Rex compared to Rsed (Table 3.1). This may
indicate the transfer of Muribaculaceae Bacterium DSM 103720 caused compositional
shifts in specific microbe abdundance in the Rex group.
To identify functional pathways that were associated with either Rsed or Rex, I ran
normalized (total sum scaling) pathway abundance data through Maaslin2. Multiple
pathways relating to nucleotide, amino acid and carbohydrate metabolism were
significantly associated with Rex compared to Rsed (Figure 3.8 A-C). Figure 3.8 A-C
show which pathways related to microbial function were significantly associated with Rex
(Green) and Rsed (Purple). The strength of the association can be seen by the coefficient
value which can be a proxy for the effect size [362].Figure 3.8 A reveals that the Rex
microbiome was significantly associated with pathways that are involved in nucleotide
biosynthesis and degradation.
Figure 3.8 B represents pathways significantly associated with amino acid
metabolism between Rsed and Rex. An interesting observation found in this analysis was
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that Rsed was associated with greater tryptophan and glutamate biosynthesis, while Rex
was associated with higher histidine biosynthesis and degradation. This suggest that the
microbiomes of each group have a propensity for specific amino acids which produce
discrete metabolites. Histidine can be metabolized by certain microbes into imidazole
propionate which has been shown to activate TORC-1 [319]. Therefore, these results
suggest that receiving the microbiome of an exercise-trained host may shift the preference
for specific amino acids which could influence (both compositionally and functionally) the
community of surrounding microbes ultimately altering the production of microbial
derived metabolites.
Figure 3.8 C shows which pathways related to carbohydrate metabolism are
associated with Rsed and Rex. One of the top pathways associated with Rex was fucose
degradation (fucose degradation and the super-pathway of fucose and rhamnose
degradation). Fucose and rhamnose is metabolized to lactaldehyde which is further
metabolized into lactate or propane-1,2-diol. Lactate and propane-1,2-diol can participate
in the formation propionate which is a SCFA known to increase with exercise [205, 364].
Additional pathways relating to formate metabolism (N10 formyl tetrahydrofolate
biosynthesis and X6 hydroxymethyl dihydropterin diphosphate biosynthesis III) and CO2
production (Calvin-Benson-Bassham Cycle, Reductive TCA cycle) were also significantly
associated with Rex (Figure 3.8 C). Formate can participate in the production of butyrate
and acetate [364]. These results suggest that the microbiome in Rex may be metabolizing
carbohydrate precursors to generate SCFAs.
Next, to obtain further insight into differences between the microbiomes of Rsed
and Rex, an additional analysis using MelonnPan was performed to identify potential
microbially-derived metabolites. MelonnPan is a computation program where abundance
files are input to predict metabolite composition [363]. Figure 3.9 A show the
Representative Training Sample Index (RSTI) for each sample. The RSTI is an indicator
of the accuracy of metabolite prediction, where the higher value RSTI (0-1) indicate a
stronger prediction [363]. The average RSTI scores were 0.359 ± 0.145 and 0.337 ± 0.17
for Rsed and Rex, respectively. There were 36 predicted metabolites to be significantly
associated with either Rsed or Rex (Figure 3.9 B). Specifically, metabolites related to lipids
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and bile acids were found to be significantly associated with Rex. Not significant by the
cut off used previously (p < 0.01 and adj. p < 0.1) a known microbial produced product of
histidine metabolism, imidazole propionate, was trending (p = 0.056, adj. p = 0.117) to be
significantly associated with Rex (Figure 3.9 B). Taken together with the histidine
metabolism pathways shown in Figure 3.8, the predictive metabolite analysis revealed the
possibility that the microbiome of Rex could be engaging in the production of imidazole
propionate through metabolizing histidine.
Discussion
The purpose of this study was to determine if the gut microbiome from an exercise trained
host could attenuate skeletal muscle atrophy induced by limb immobilization. The major
finding from this study is that the gut microbiome from an exercise-trained mouse can blunt
soleus muscle atrophy as assessed by the percent decrease in mean fiber CSA and fibertype specific CSA between the non-immobilized and immobilized limb. The gut
microbiome from an exercised mouse was also found to preserve the abundance of Type2a fibers in the Rex group compared to Rsed group, suggesting that an exercise-trained
microbiome can influence skeletal muscle fiber-type transition induced with muscle
atrophy. These findings provide new evidence demonstrating unique properties of the gut
microbiome of an exercise-trained individual and add to the growing literature supporting
the existence of a skeletal muscle-microbiome axis [197, 199, 201, 248, 352].

To elucidate a mechanism metagenomic sequencing was performed on the cecal
contents taken from the donors and recipients. The metagenomic analysis revealed
significant difference in the composition and function of the gut microbiome between Rsed
and Rex. These differences are consistent with the literature which has shown exercise can
modulate the gut microbiome [365]. Compositional differences between Rsed and Rex
indicated discrete microbes that were highly abundant in one group and either extremely
low or not found in the other group. Analysis of β-diversity further revealed that Rsed and
Rex were significantly different compositionally, suggesting the transfer of the donor
microbiome caused significant shifts in the microbiota. Interestingly, when comparing the
Dex and Rex groups, there were also significant differences in microbial composition, a
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difference not found when comparing Dsed and Rsed. When taking into consideration the
top 10 most abundant species, there were no observable differences between Dex and Rex.
This finding indicates that lowly abundant species most likely accounted for the differences
between Dex and Rex. This finding indicates there are species sensitive to exercise that
were present in Dex but did not engraft in Rex, thus suggesting these species require
ongoing exercise to maintain their abundance within the gut microbiome. As reported by
Grosicki and colleagues, the genus Veillonella increased 143-fold in an individual who just
completed a 161-km run [206]. Scheiman and co-workers also determined that Veillonella
abundance was higher immediately post-marathon race compared to later time points
[205]. These data provide compelling evidence that specific gut microbes are responsive
to exercise as shown by a transient increase in their abundance following exercise. This
finding has important implications for future studies, performing microbial transfer from
an exercise-trained host into a non-exercising recipient may require the recipients to
exercise to maintain microbial composition of the donor. While speculative, this finding
suggests that soluble factors generated during exercise, possibly from skeletal muscle,
positively influence the activity of specific gut microbes [366]. Additionally, the systemic
effects of exercise may also impact the gut microbiome through the redistribution of blood
to the gastrointestinal tract, changes in pH, increases in core temperature and mechanical
perturbations of the gastrointestinal tract that accompany some forms of exercise. Future
studies will need to determine how exercise directly affects the growth of the gut
microbiota and if these compositional changes are associated with concomitant functional
changes.
The most intriguing finding from the study was the identification of the Dex-specific
microbe Muribaculaceae bacterium DSM 103720 which was successfully transferred to all
Rex mice. While it remains to be tested, Muribaculaceae bacterium DSM 103720 may
further influence the composition of the gut microbiome by directly affecting the growth
and/or function of other microbes. In support of such a scenario, the abundance of
Akkermanisa muciniphila, Ileibacterium valens and Faecalibacterium rodentium were
significantly higher (and within the top 20 most abundant taxa) in the Rex compared to
Rsed group. The gut microbiota represents a highly dynamic and connected community
and the microbes share core bioenergetic machinery, such as the electron transport chain,
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hemes, quinones and amino acids in the extracellular space, termed the “Pantryome”,
which influences the functional capabilities of individual microbial species [367]. As an
example, Daisley and co-workers suggest the Pantryome helps to create a reservoir of
resources whereby if a primary degrader produces products with insufficient carbon-based
energy, the secondary degraders may utilize what is in the pantryome in order to carry out
their respective roles [367]. In support a pantryome, Li and co-workers showed the
synthesis of the metabolite isoalloLCA was dependent upon the activity of three different
bacteria, revealing a network of microbes drives the generation of precursor molecules
needed for the final product [368]. This finding highlights the interconnectedness of the
microbial community of the gut microbiome in which the production and consumption of
intermediates that ultimately result in metabolites that can affect the host [369].
The composition analysis presented here, suggest that the transfer of Muribaculaceae
bacterium DSM 103720 from Dex to Rex, promoted the growth of additional bacteria, that
was not observed in the Rsed group. Akkermanisa muciniphila, Ileibacterium valens and
Faecalibacterium rodentium were significantly higher in Rex compared to Rsed. In
addition, although not significant, Bacteroides thetaiotamicron was almost 50% more
abundant in Rex compared to Rsed (Table 3.1). These bacteria are known to produce or
are associated with SCFAs [370-372]. Additionally, Akkermansia munciniphila and
Bacteroides thetaiotamicron can degrade fucose which is abundant in host mucosal
surfaces [373, 374]. Fucose degradation was one of the pathways significantly associated
with Rex, which could indicate enhanced SCFA production.
A deeper analysis of the metagenomic analysis revealed a significant association in
histidine biosynthesis and degradation in Rex compared to Rsed. The analysis from
MelonnPan also indicated that the metabolite imidazole propionate was trending to be
significantly associated with Rex. Ammonia lyase is an enzyme that catalyzes the
elimination of the alpha-amino group converting histidine to urocanic acid [375]. Urocanic
acid is subsequently reduced to imidazole propionate by the microbial enzyme urocanate
reductase [376]. Imidazole propionate was first shown to contribute to insulin resistance
by activating TORC-1 in a p62 phosphorylation dependent mechanism, leading to
desensitized insulin receptor substrate [319]. These findings indicate that imidazole
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propionate has a negative effect on host health by impairing glucose metabolism. Most
recently a study found protective effects of imidazole propionate against irradiation
induced toxicity of the pulmonary system by attenuating pyrotosis in the lung [377]. These
authors also found that treating mice with L-histidine resulted in an increase in
Ileibacterium valenes, Akkermanisa munciniphilia, both of which were significantly higher
in Rex compared to Rsed.

These results provide a potential mechanism where

transplanting the gut microbiome from an exercised-trained host results in an increase in
imidazole propionate, driven by enhanced histidine and SCFA metabolism, that could
ameliorate skeletal muscle atrophy through TORC-1 stimulation.
The proposed mechanism contrasts with previously published literature which has
demonstrated negative health implications of imidazole propionate regarding glucose
metabolism [319, 378, 379]; though these negative implications are primarily observed in
patients with type 2 diabetes. Although not detected with MelonnPan, the metagenomic
analysis revealed pathways related to SCFA production were higher in Rex. The potential
of SCFAs to regulate host health and skeletal muscle is an active area of research [242,
380]. SCFAs are also associated with improvements in insulin sensitivity and increase
energy expenditure [381]. The results from this study suggest an interconnection of
microbial-derived metabolites. Both the production of imidazole propionate and SCFAs
may act in synergy, such as seen with different hormones [382]. Synergism between SCFA
and phenolic metabolites was demonstrated by Zheng and co-workers. These authors
showed that butyric acid in combination with three phenolic acids had a greater capacity
to reduce TNF-α and NK-κβ signaling in Caco-2 cells [383]. These results highlight that
microbial-derived metabolites may work in tandem and/or potentiate one another’s effect
on the host.
An important consideration regarding the effect of imidazole propionate and other
metabolites may be context dependent. This has been seen elsewhere when looking at
branch chained amino acids (BCAA). In terms of skeletal muscle hypertrophy, especially
mTOR activation, BCAAs can stimulate protein synthesis and are considered to enhance
anabolic activity [384]. In contrast, studies have demonstrated potential negative
consequences of BCAA in terms of glucose metabolism, suggesting that BCAA activation
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of TORC-1 leads to phosphorylation and subsequent inhibition of insulin receptor substrate
[385, 386]. This paradox may be explained by other factors such as lifestyle, diet, disease
and age could influence how metabolites (both microbial-derived and host-derived)
regulate physiology. For example, Molinaro and co-workers concluded that imidazole
propionate is associated with a pro-inflammatory microbiota. One of the microbes they
found to be pro inflammatory was Veillonella atypica [379]. This microbe has recently
been shown to be abundant in elite endurance athletes and improved exercise time to
exhaustion when administered to mice [205, 206]. In the context of highly trained athletes,
Veillonella is thought to be highly beneficial to endurance activity, whereas in a sedentary
lifestyle, the absence of exercise could shift the function of this microbe towards an
inflammatory phenotype. This reinforces the idea that the function of a particular microbe
may be due in part to the behavior of the host and the surrounding community of microbiota
within an environment. Therefore, stating that a microbe or a microbial derived metabolite
is harmful or beneficial depends on numerous factors such as host lifestyle, diet, age and/or
community of microbes that comprise the microbiome.
Limitations
The results from this study are not without limitations. Due to laboratory constraints, the
cecal slurry used to transfer into recipient mice was prepared under aerobic conditions.
Aerobic conditions likely killed microbes which are highly sensitive to oxygen, thus
altering the composition of the cecal contents that were present for transfer. Recently Hunt
and co-workers demonstrated that the integrated transcriptomic and proteomic response to
different atrophy conditions varies across conditions [387]. Therefore, the ability of gut
microbiome of exercise-trained mice to ameliorate muscle atrophy may in fact be specific
for atrophy induced by limb immobilization and not necessarily applicable to other forms
atrophy caused by denervation, muscle wasting diseases such as cancer cachexia or aging.
MaAsLin2 was used to determine significant association between gene features and
groups. Due to linear models being bias towards larger samples size, the results from this
analysis may not have accurately encompassed all of the significant relationships [362].
The metabolite prediction software, MelonnPan, was originally trained using microbiome
and metabolites collect from humans [363]. The input used in the current experiment came
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from the microbiome of mice, which could limit the accuracy of the MelonnPan’s
performance. A future study should focus on determining the serum concentration of
imidazole propionate with the prediction it will be higher in Rex mice compared to Rsed
mice, and determining how imidazole propionate effects skeletal muscle alone or on
conjunction with SCFAs. It will also be important to demonstrate that the microbiome of
Rex mice can generate these metabolites.
In conclusion this is the first study to demonstrate that the microbiome from an
exercised-trained host can mitigate skeletal muscle atrophy in a host undergoing limb
immobilization. The potential mechanism mediating this finding is thought to be due to the
synergistic effect of the microbial derived metabolites imidazole propionate and SCFAs.
This is driven by the addition of Muribaculaceae bacterium DSM 103720, which acts as
an influencer to other microbes, facilitating their growth and subsequent metabolism of
fucose and histidine. While the findings await further conformation, the results provide a
potential new therapeutic strategy to combat the loss of skeletal muscle and additional
evidence of the skeletal muscle-gut microbiome axis.
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Table 3.1Top 20 Significantly Different Taxa Between Recipient Groups
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Figure 3.1No Adverse Effects of CMT or Immobilization on Body Weight or
Food Consumption
A) Overview of experimental design, B) Schematic for cecal microbial transfer, C)
Representative images of immobilization technique; D) Body weights during
experimental period; E) Food consumption during experimental period; F) Total running
volume of each group of exercise trained donors during 8-weeks of PoWeR training. † =
p < 0.05 when comparing Rsed body weights in week 1 to weeks 5-7. * = p < 0.05 when
comparing Rex body weights in week 1 to weeks 5-8 and week 2 to week 8.
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Figure 3.2The Gut Microbiome from an Exercised Trained Host Blunts Skeletal
Muscle Atrophy in the Soleus
A) representative images of soleus muscle, B) Normalized wet weight to body weight, C)
Comparison of mean fiber cross-sectional area (CSA) in non-immobilized and
immobilized limbs, D) Comparison of Type-1 fiber mean fiber CSA in non-immobilized
and immobilized limbs, E) Comparison of Type-2A fiber mean fiber CSA in nonimmobilized and immobilized limbs, F) The percent difference in mean fiber CSA
between non-immobilized and immobilized limb for each recipient group, G) The percent
difference in mean Type-1 fiber CSA between non-immobilized and immobilized limb
for each recipient group, H) The percent difference in mean Type-2A fiber CSA between
non-immobilized and immobilized limb for each recipient group, I) Percent Type-1 fiber
abundance in non-immobilized and immobilized limbs, J) Percent Type-2A fiber
abundance in non-immobilized and immobilized limbs, K) Percent Type-2B+X fiber
abundance in non-immobilized and immobilized limbs. * = p < 0.05.
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Figure 3.3Alpha Diversity Measures in Recipient and Donor Mice
Box plots displaying α- diversity measures on A) recipients only and B) donors only. * =
adj. p = 0.0059.
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Figure 3.4 Beta Diversity Measures in Recipient and Donor Mice
A) Principal component analysis showing the effects of CMT on recipient groups at the
end-point of the experiment. B) Principal component analysis of the donors. Distance
metric Weighed Bray-Curtis.

76

Figure 3.5 Comparison of Donor and Recipient Microbiomes
A) Principal component analysis comparing sedentary donors and their respective
recipients, B) Principal component analysis comparing exercise trained donors and their
respective recipients, distance metric Weighted Bray-Curtis, C) Stacked bar plots
representing the top 10 most abundant species between donors and their respective
recipients, D) Violin plots comparisons between the top 10 most abundant taxa between
the donors and their respective recipients.
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Figure 3.6 Genera and Species Comparison Between Donors and Recipients
Stacked bar plots showing differences in the top 20 most abundant genre (A) and top 15
most abundant species (B).
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Figure 3.7 Species Comparison Between Recipients Groups
A) Stacked bar plot showing top 15 most abundant species between donors and
recipients, separated by training status of the donor, B) Violin plots comparing the top 15
most abundant species between Rsed and Rex. * Adj. p < 0.1, p < 0.05. Muribaculaceae
bacterium DSM 103720 is colored black to highlight its abundance profile.
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Figure 3.8 Gene Pathway Analysis
Comparison of gene pathways significantly associated with Rsed or Rex A) nucleotide
Metabolism, B) Amino acid metabolism, C) Carbohydrate metabolism. Pathways listed
are significant adj. p <0.1 and p < 0.05. Coefficient refers to effect estimate.
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Figure 3.9 Predictive Metabolite Analysis
A) Representative Training Sample Index (RSTI) scores, B) Predictive metabolite
significantly associated with Rsed or Rex. Pathways listed are significant at p < 0.05.
Coefficient refers to effect estimate.
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CHAPTER 4. DISCUSSION

Major Findings from Dysbiosis of the Gut Microbiome Impairs Mouse Skeletal Muscle
Adaption to Exercise.
This was the first study to demonstrate that antibiotic-induced dysbiosis impaired the
ability of skeletal muscle to adapt to exercise. This effect was seen in both the
hypertrophic response in the soleus (Figure 2.6) and fiber-type shift in the plantaris
muscles (Figure 2.9). This study also revealed that antibiotic-induced dysbiosis interfered
with satellite cell fusion in the plantaris muscle, an observation not seen in the soleus
(Figure 2.8). These results demonstrate the influence of the gut microbiome on skeletal
muscle is specific to each muscle, likely reflecting the difference in fiber-type
composition between the soleus and plantaris muscles (Chapter 1.1.2).
The analysis of satellite cell abundance in the plantaris muscle revealed that
satellite cells in the antibiotic-treated runners did not adequately fuse into the muscle as
observed in the non-treated runners. This finding raises the intriguing possibility that the
microbiome may regulate skeletal muscle stem cell i.e., satellite cell, dynamics in skeletal
muscle. In support of this possibility is the results using germ-free mice in which the
expression of myogenic regulatory factors, MyoD and MyoG, were downregulated
compared to SPF mice [199]. The MyoD knockout mouse was shown to have defective
satellite cells that exhibited dysregulated differentiation, fusion and formed large
aggregates [388]. If the gut microbiome modulates myogenic regulatory factor expression
through a yet-to-be described mechanism, then it is plausible that dysbiosis could have
disrupted such a mechanism resulting in diminished satellite cell fusion to myofibers
during adaptation to PoWeR training (see Figure 2.8). While speculative, but none-theless exciting, these results indicate the gut microbiome can influence the fate of satellite
cells, as seen in other stem cell populations [389].
Another finding from this study was that antibiotic administration did not interfere
with exercise performance (Figure 2.5). This finding was significant due to the fact that
prior studies utilizing germ-free mice or high doses of antibiotics reported exercise
intolerance [202, 317]. The dose of antibiotics utilized in our study was much lower
82

compared to doses previously used (in both concentration and amount of antibiotics)
[250, 317] yet we were able to effectively induce dysbiosis (Figures 2.2 & 2.3) with no
signs of adverse effects. This result was critical to the study because the exercise
stimulus, i.e., the amount of running, promoting muscle adaptation was the same between
the two running groups, thus allowing us to make stronger conclusions regarding the role
of the gut microbiome on skeletal muscle adaptation. Additionally, future studies
investigating the role of the gut microbiome in muscle adaptation can use the dose of
antibiotics we used without compromising exercise capacity or muscle function.
Major Findings from The Gut Microbiome from an Exercise-Trained Host Ameliorates
Skeletal Muscle Atrophy
The results from this study demonstrate that the gut microbiome from an exercise-trained
host significantly attenuated skeletal muscle atrophy in the soleus muscle induced by
hind-limb immobilization (Figure 3.2). This is a novel finding in the field of skeletal
muscle-gut microbiome research, as it offers a clear therapeutic potential of the
microbiome from an exercise-trained host to reduce the degree of atrophy caused by
disuse. These results are in line with a recent paper which also showed the gut
microbiome can mitigate skeletal muscle atrophy through the administration of the SCFA
butyrate [200]. In addition to affecting muscle atrophy, I also found that recipients of the
exercise-trained gut microbiome (Rex), had higher abundance of Type-2A fibers in the
immobilized leg compared to recipients of gut microbiome from sedentary mice (Rsed)
(Figure 3.2). This finding indicates the gut microbiome from an exercised-trained host
can also modulate fiber-type composition. These findings are in support of my previous
research (discussed in Chapter 2 and 4.1)[352] and other research which has shown the
gut microbiome can influence fiber-type composition of a muscle [197].
To understand how the gut microbiome from an exercise-trained host regulates
skeletal muscle atrophy, the cecal contents from donor and recipient mice were sent for
metagenomic sequencing. Initial analysis revealed that the Rex group had significantly
more observed taxonomical units (OTUs) compared to Rsed, however, there was no
differences in α-diversity (Figure 3.3A). These findings suggest that collectively, Rex
had more low abundant species (increased species richness) compared to Rsed, with no
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changes in species evenness. The analysis did not focus on these lowly abundant species
but that does not negate their potential importance for future studies [390]. β-diversity
analysis showed a clear distinction between Rsed and Rex, indicating these two groups
had significantly different microbiomes (Figure 3.4 A). When β-diversity analysis was
performed comparing the donor and their respective recipient, it was found that there was
significant difference between Dex and Rex, a finding not observed when comparing
Dsed and Rsed (Figure 3.5 A). Currently there is not a definitive explanation for why
these Dsed and Rex are different, but I propose this difference is due to the absence of
exercise in the recipient group. The donors in Dex had undergone eight weeks of
progressive weighted wheel running (PoWeR) prior to cecal collection. These mice were
running approximately 10-12km a night against a load that was roughly 25% of their
body weight (Figure 2.5). The Rex group remained sedentary throughout the
experimental period which may have affected exercise-dependent microbial species.
This conclusion is supported by a recent study that demonstrated rapid shifts in microbial
abundance before, immediately after, and 10 days post-100 mile ultramarathon [206].
The physical act of exercise may be a potent stimulus for specific microbes, causing a
significant change in their abundance. Cessation of exercise may reverse these changes
in abundance, which could also influence the surrounding pool of microbial-derived
metabolites that could potentially interact with the host.
The metagenomic analysis revealed many different pathways that were
significantly associated with Rex compared to Rsed (Figure 3.8 A-C), suggesting the
transfer of an exercise-trained microbiome significantly altered the functional capacity of
the recipient microbiome. This interpretation is supported by the compositional data
showing 1) the microbe Muribaculaceae bacterium DSM 103720 which was only
observed in Dex successfully transferred to all Rex and 2) microbes that were of low
abundance in Rsed were significantly more abundant in Rex (Table 3.1). Therefore, I
conclude that the microbiome from an exercise-trained host containing Muribaculaceae
bacterium DSM 103720 significantly changed both the composition and function of the
recipient microbiome. The functional changes are reflected in specific pathways related
to carbohydrate and amino acid metabolism, indicating an increase fucose, rhamnose and
histidine metabolism, which could drive the production of the imidazole propionate and
84

propionate, respectively. This conclusion is supported by the predicted metabolite
analysis, showing imidazole propionate is significantly associated with Rex (Figure 3.9
B). In skeletal muscle, imidazole propionate and propionate have been shown to activate
TORC-1 [200, 319], increase the protein levels of PGC-1α [391], lower the expression of
atrogenes [199] and serve as an alternative fuel source [205]. I propose a mechanism that
connects these two microbial derived metabolites which caused the attenuated atrophic
response seen in the Rex group induced by hind-limb immobilization. This predicted
pathway needs to be validated by additional experiments; however, this hypothesis posits
that microbial-derived metabolites work in tandem to elicit a response in skeletal muscle.
The Gut Microbiome and Skeletal Muscle Mass
The results from my dissertation provide evidence that the gut microbiome contributes to
the regulation of skeletal muscle mass. This was seen in both an anabolic condition
where, hypertrophy was blunted with dysbiosis, and a catabolic condition, where the
microbiome, which was modulated by exercise, had the capacity to attenuate skeletal
muscle atrophy. The result from this work agrees with other studies showing that
skeletal muscle mass can be modulated by the gut microbiome. For example, Lahiri and
co-workers found that skeletal muscle from germ-free mice are atrophic [199]. Upon
colonization, germ-free mice showed an increase in skeletal muscle mass [199]. These
results have been seen in other germ-free animals such as piglets. Skeletal muscle taken
from germ-free piglets had a significantly smaller fibers compared to piglets with a
microbiome [392]. Performing a fecal transplant into the germ-free piglets shifted the
fiber size distribution towards larger fibers [392]. Administration of antibiotics to mice
to deplete the gut microbiome resulted in significant atrophy in the leg muscles [338].
These authors further determined the muscle atrophy was not driven by the antibiotics
themselves, rather aberrant bile acid signaling, which led to a decrease in phosphorylation
of rpS6 through extracellular signal-regulated protein kinase (ERK) [338]. The results
from my dissertation further demonstrate that skeletal muscle mass can be modulated by
the gut microbiome. I also provide novel evidence that skeletal muscle fiber-type
specific hypertrophy is differentially regulated by the gut microbiome. For example, in
the plantaris muscle, both the Type-2A fibers hypertrophied in the untreated and treated
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runners (Figure 2.8). Looking at the Type-2B+X fibers, only the untreated runners
showed significant hypertrophy. This is the first time these results have been shown,
demonstrating a high degree of specificity in the interaction between the gut microbiome
and skeletal muscle.
The Gut Microbiome and Skeletal Muscle Fiber-type
The result from this study also found that skeletal muscle fiber-type composition is
sensitive to changes in the gut microbiome. In support of this finding, Yan and coworkers took the feces from two different species of pigs, which had distinct fiber-type
compositions, and transferred the microbiome into germ-free mice. These authors found
that the recipient mice exhibited similar skeletal muscle fiber-type composition as the
donor pigs [197]. Bäckhead and co-workers determined the skeletal muscle of germ-free
mice had significantly higher expression of phosphorylated AMP-activated protein kinase
(AMPK), phosphorylated acetyl-coA carboxylase (ACC) and carnitine
palmitoyltransferase (CPT) compared to conventionalized mice [193]. These data suggest
that germ-free muscle had a higher capacity for lipid oxidation and possibly higher
mitochondrial content. Although skeletal muscle fiber-type composition was not
measured, the results are still indicative of a higher abundance of oxidative fibers in
germ-free muscle These experiments were performed in the gastrocnemius muscle which
in the mouse is typically considered more glycolytic, mostly comprised of Type-2B and
Type-2X fibers [393]. The data from germ-free mice suggest there may have been a shift
towards the more oxidative Type-2A fibers. In comparison, when the microbiome was
disrupted with antibiotics, Qui and co-workers did not find any changes in fiber-type
composition [338]. Currently, there is not a defined mechanism for how the gut
microbiome exerts an effect on fiber-type composition, though speculations in fiber-type
composition changes may be mediated by microbially derived SCFAs [242, 394]. Dietary
acetic acid supplementation was shown to significantly increase the expression of AMPK
and peroxisome proliferator-activated receptor-delta (PPAR-δ), which was correlated to a
significant increase in oxidative fibers in the soleus muscle of the mouse [391]. This
potential mechanism is consistent with the finding showing PPAR-δ is a downstream
target of AMPK with activation of PPAR-δ associated with an increase in oxidative (slow
86

twitch/Type-1) fibers [395]. Determining if SCFAs produced from the gut microbiome
directly interact with skeletal muscle in-vivo remains to be directly tested. Future work
will need to define such a pathway and demonstrate mechanistically how SCFA and/or
other gut microbial-derived metabolite(s) regulate skeletal muscle mass and fiber-type
composition.
Future Directions
Alternative Strategies to Induce Dysbiosis
This study used antibiotics to induce dysbiosis and disrupt the gut microbiome. It would
be interesting to use another method which causes disturbances to the gut microbiome
such as dietary manipulations. Diet exerts a strong stimulus to change both the function
and composition of the microbiome [211]. A high-fat diet, in particular, has been shown
to cause a pro-inflammatory microbiome [326] that is associated with cardiovascular
disease, colon cancer and obesity [396-398]. It would be interesting to determine if a
high-fat diet induced a dysbiotic state of the gut microbiome that resulted in impaired
skeletal muscle adaptions to exercise. Furthermore, such a study could determine if
exercise might help resolve dysbiosis of the gut microbiome caused by a high-fat diet.
The extent of the beneficial effects of exercise on the gut microbiome are still being
discovered. More research is needed to ascertain the extent by which exercise causes
changes to the gut microbiome that result in beneficial effects to the host.
Identifying Gut Microbial Derived Metabolites that
Regulate Promote Skeletal Muscle Hypertrophy.
This study did not identify a mechanism for how the gut microbiome regulates
skeletal muscle adaptions to exercise. Future research should begin to address this gap in
knowledge. Recently, Han and co-workers showed that there are 833 metabolites
associates with microbial metabolism [399]. Knowledge of how exercise modulates this
pool of metabolites remains incomplete. As discussed in Chapter 1, there are many
potential gut microbial-derived metabolites that may be modulating skeletal muscle.
SCFAs are the most studied in relation to skeletal muscle [199, 200, 205, 317] but this
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does not preclude novel metabolites that arise from exercise modulation of the
microbiome. Future studies need to incorporate strategies that can clearly distinguish
between gut microbial metabolites from host-derived metabolites, and if these
compounds have the capacity to regulate skeletal muscle.
Utilizing stable isotope tracing, future experiments can begin to determine which
compounds produced from the microbiome contribute to the regulation of skeletal muscle
adaptions to exercise. This can be performed by administering 13C-inulin, a fermentable
fiber specifically metabolized by intestinal bacteria, to rodents to track the flux of labeled
carbons to muscle. Lund and co-workers recently validated this method in-vivo and
demonstrated that the microbiome provides carbons which ultimately participated in
histone acetylation within intestinal epithelial cells [253]. Performing this experiment in
exercising hosts, along with non-exercising controls, provides a potential method to
identify which gut microbial-derived metabolite(s) interact with muscle and how such
metabolites may change with exercise. Another important aspect of such an experiment
would be the ability to better define how exercise is able to influence microbial
metabolism. Understanding how exercise alters the metabolic output from the gut
microbiome is an important consideration when describing the crosstalk between the gut
microbiome and host.
Validating and Testing Imidazole Propionate and
Propionate
I propose that imidazole propionate and propionate are acting synergistically to blunt
skeletal muscle atrophy induced by hind-limb immobilization. The gut microbiome was
found to produce over 800 different metabolites, and it has been recently shown that the
microbial-derived metabolites butyric acid in combination with either benzoic acid,
phenylacetic acid or phenylpropionic acid, potentiated a decrease in TNF-α induced
secretion of Il-8 [383]. These results suggest gut microbial-derived metabolites may act
synergistically with one another to elicit a response in the host. To test the proposed
mechanism an in-vitro model using myotubes could be employed along with imidazole
propionate treatment in combination with propionate. Using myotubes I could test the
hypothesis that imidazole propionate in combination with propionate stimulates skeletal
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muscle protein synthesis and increases oxidative metabolism. If the results from such an
in-vitro experiment support my hypothesis, I could subsequently move to an in-vivo
model to determine if they can be recapitulated. This method of administering microbial
metabolites directly, termed postbiotic, may be preferred over trying to directly alter
certain microbes with dietary sources (prebiotic) or by consuming a high number of a few
species (probiotic) [400]. Currently the efficacy of probiotics is limited and has risks via
aberrant interactions with resident microbes which may lead to adverse events in the host
[401]. Prebiotics refer to anything that the gut microbiota can metabolize which effects
the composition and function of the microbiome [402]. Prebiotics have been shown to be
a powerful method to modulate the microbiome at the single strain level [403]. A
potential contraindication of prebiotics is that the compositional and functional changes
may not result in universal benefits to the population [401]. The inter-individual response
to prebiotics may limit the extent to which this approach can be used clinically.
Therefore, identifying the gut microbial-derived metabolites that exert beneficial effects
to the host may be the most advantageous route for therapeutic use.
Upon the identification of the specific pathways that connects gut microbialderived metabolite(s) to skeletal muscle, additional experiments could be performed to
validate the findings. If for example, the candidate metabolite(s) bind to a specific
receptor on skeletal muscle, the expression of the receptor could be genetically
manipulated. SCFAs fatty acids bind to G-coupled protein receptor (GCPR) known as
free fatty acid receptor (FFAR 1,2, 3 and 4) which are expressed in tissues such as the
heart, immune, adipose and skeletal muscle [244, 404]. Tang and co-workers
demonstrated that the SCFA butyrate upregulated the expression of FFAR2 in myotubes
leading to enhanced phosphorylation of TORC-1[200]. Future experiments utilizing
transgenic mice could directly modulate the expression of FFAR2 in skeletal muscle to
determine the if this pathway is one way by which SCFAs produced by the gut
microbiome regulate a hypertrophic response in skeletal muscle.

An additional metabolite that was found to be significantly associated with Rex
was bile acids, specifically chenodeoxycholate and cholate (Figure 3.9 B). Secondary bile
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acids produced from the gut microbiome have been shown to ameliorate antibiotic
induced skeletal muscle atrophy by increasing the release of fibroblast growth factor 15
(FGF15) from intestinal epithelial cells [338]. Secondary bile acids were also shown to
act as a ligand for the GCPR TGR5, which is expressed in skeletal muscle. Sasaki and coworkers showed that direct oral administration of the secondary bile acid taurolithocholic
acids (TLCA) resulted in significant skeletal muscle hypertrophy [263]. However, no
study has yet demonstrated that secondary bile acids produced from the gut microbiome
bind to TGR5 receptors in skeletal muscle. Thus, a possible mechanism for how the
exercise-trained gut microbiome might mitigated skeletal muscle atrophy may involve
bile acid metabolites such as TLCA.
Other Models of Atrophy
It has been recently shown that different models of atrophy elicit distinct transcriptomic
and proteomic signatures [387]. Taking this into consideration, a future study should
focus on other models of atrophy to determine if the gut microbiome from an exercisetrained host exerts the same beneficial response. Such knowledge will be important for
determining the therapeutic potential of the microbiome to broadly treat the various
conditions known to cause a loss of skeletal muscle mass. Extending the findings of my
study into other models of atrophy has the potential to impact other conditions, such as
space exploration and systemic diseases, where the underlying mechanism promoting
muscle atrophy have been shown to differ [145].
Characterizing Muribaculaceae bacterium DSM
103720
As mentioned previously, the microbe Muribaculaceae bacterium DSM 103720 was
observed in Dex and Rex, while absent from Dsed and Rsed. This indicates
Muribaculaceae bacterium DSM 103720 responded to exercise training in the Dex group
and was able to proliferate in Rex. Muribaculaceae bacterium DSM 103720 is not wellcharacterized but other members belonging to the same genus were shown to be enriched
with genes relating to complex carbohydrate degradation and protein translation [405,
406]. Chung and co-workers reported that Muribaculum (Taxonomic Level-Family)
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contained many genes involved in protein translation, which was consistent at the
metatranscriptomic level [406]. These authors found that the higher abundance of
translation-related pathways resulted in an increase in transcripts associated with
ribosomal proteins. A detailed inspection of the current metagenomic analysis revealed
that out of the 10 species contributing to the tRNA charging pathway, Muribaculaceae
bacterium DSM 103720 contributed almost 25% of the total pathway (data not shown).
The metagenomic analysis in the current study is in line with previous research
suggesting Muribaculaceae bacterium DSM 103720 has a high capacity for complex
carbohydrate utilization and protein translation. More experiments need to determine if
and how this impact surrounding microbes and host which harbor this species.
The change in the abundance of other microbes due to the presence of
Muribaculaceae bacterium DSM 103720 may also be matched with an increase in their
function leading to enhanced metabolite production. In support of this scenario, Wu and
co-workers demonstrated that genetic depletion of hypoxia inducible factor 2A alpha
(HIF-2α) in the intestines, decreased lactate levels, which suppressed the levels of
Bacteroides vulgatus. The decrease in Bacteroides vulgatus abundance was shown to
cause a greater increase in Ruminococcus torques, that led to an increase in taurineconjugated cholic acid (TCA) [407]. It was not described how Bacteroides vulgatus
modulates Ruminococcus torques, but it does demonstrate that microbes can influence the
abundance of fellow microbes within an environment, which impacts the pool of
available metabolites. The reliance of gut microbes upon one another is thought to reflect
the fact that some microbes lose certain genes over evolution (auxotroph), which then
cause them to rely on other microbes to produce nutrients required for their survival and
ability to grow [367]. Thus, the presence of a particular microbe, such as Muribaculaceae
bacterium DSM 103720, may lead to the production of essential nutrients or components
of translation that other species, such as Akkermanisa munciniphila, Faecalibaculum
rodentium, Parasutterella excrementihominis and Ileibacterium valens need for their
viability within the gut.
A future set of experiments could begin to characterize Muribaculaceae
bacterium DSM 103720. As demonstrated by Hoffman and colleagues, utilization of fecal
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cell suspensions led to the characterization of a novel microbe (JB12), an Acutlibacter
species from the family Ruminococcaceae [408]. This technique involves isolating
microbes from feces and suspending them in growth media, removing the influence of the
host or other environmental factors [220]. Muribaculaceae is a strict anaerobe of the
Bacteroidales order; other members of this order have been successfully isolated from
cell suspensions, streaked on agar isolates and supplied with a mucus media [405].
Collecting the feces from exercise-trained mice and performing a series of growth
experiments can led to the isolation of a species like Muribaculaceae bacterium DSM
103720 (which can be validated by whole genome sequencing). The complete metabolic
fingerprint of Muribaculaceae bacterium can then be identified by incubation of isolates
in pure culture and collecting media at a time point that reflects optimal growth.
Additional fecal cell suspensions with feces from exercise naïve mouse can be used to
directly add Muribaculaceae bacterium into these cultures. Metabolomics can then be
performed on fecal cell suspensions with or without the addition of Muribaculaceae
bacterium to determine how this microbe specifically shapes the gut microbiome and
shape the metabolite profile.
The fecal cell suspension also offers another means to interrogate if exercise leads
to the production of novel gut microbial metabolites. Our group determined that
performing fecal cell suspension supplemented with 13C-inulin, allowed for the
quantification of microbial-derived metabolites [220]. This experiment can be performed
using feces from exercise-trained and untrained hosts to determine how exercise alters the
metabolic output. Subsequently, metabolites that appear to be associated with a
microbiome from an exercise-trained host can be directly studied to determine their
potential to regulate skeletal muscle mass.
Conclusion
In conclusion, the work performed during my dissertation has demonstrated that the gut
microbiome contributes to skeletal muscle plasticity, as seen in both a hypertrophic and
atrophic setting. The mechanism(s) involved are not fully elucidated. Future experiments
will work to unravel how the gut microbiome specifically regulates skeletal muscle
plasticity. Additional experiments are needed to understand the complex interaction
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between microbes within an environment and how they influence the behavior of the
surrounding species. Finally, this work has brought to attention that microbial metabolites
may not be working independently from one another and in fact act as a consortium.
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